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ABSTRACT 
Background 
Wheat is one of the six most common foods responsible for food allergies in children and is introduced into the diet early in 
life. In children ingestion of wheat can lead to a variety of clinical manifestations, including cutaneous, gastrointestinal and 
respiratory symptoms. The methods commonly used in clinical practice to diagnose wheat allergy (WA) - medical history, 
skin prick test and IgE-antibodies (IgE-ab) to wheat are of limited value in diagnosing clinically relevant WA. One reason for 
this may be that wheat, since it is a grass from the Poaceae family, contains several allergenic proteins, many of which are 
known to cross-react with grass pollen allergens. An oral challenge test is recommended to confirm WA diagnosis. Since 
wheat is such a commonly used food, a food restriction can be complicated both for the affected individual as well as for 
the family. 
Aim 
The aim of this thesis is to study the utility of different diagnostic methods to identify truly wheat allergic patients. 
Furthermore we wanted to compare the impact of WA and grass allergy on the quality of life (QoL) of children with 
diagnosis wheat or grass allergy and their parents’. 
Method 
Sixty-three children diagnosed with wheat allergy (wheat group) and 72 grass allergic children (grass group) responded to a 
quality of life questionnaire and provided blood. The wheat group underwent an open wheat challenge where the children 
were eating increasing amounts of wheat under controlled conditions. IgE- ab against wheat, ω-5 gliadin, low molecular 
weight glutenin (LMW glutenin), high molecular weight (HMW glutenin) and the α-, β-, γ-, and ω-5 gliadin (gliadin) were 
analysed. Grass allergic children were analysed for seven grass-specific components (Phl p 1, Phl p 2, Phl p 4, Phl p 5, Phl p 6, 
Phl p 7, Phl p 11 and Phl p12), three wheat-specific allergen components (Tri a 14, Tri a 19 and gliadin), as well as cross-
reacting carbohydrate determinants (CCD). Blood samples for CD-sens (basophil activation analysis) were taken for 24 
individuals in wheat group. Inhibition test was used to analyse whether there is cross-reactivity between wheat and grass. 
This is done by to the patient's serum adding an extract of an allergen; antibodies bind to the allergen and then measure the 
residual activity.  
Results 
Half of the wheat allergic individuals tolerated wheat at the challenge (non-WA). The IgE-ab level against ω-5-gliadin was 
significantly higher in the WA compared to the non-WA children. All children in the WA group had IgE-ab against ω-5 gliadin, 
low respectively high molecular weight glutenin and/or gliadin. We could also see a positive correlation between levels of 
IgE-ab against these components and the severity of the reaction. A majority of the grass allergic children had low levels of 
IgE-ab to wheat (median 0.52 kUA/L) and 87% had IgE-ab to birch. By inhibition we investigated whether cross-reactivity 
between grass pollen and wheat could be explained by two allergens commonly found in grass, profilin and CCD. These 
components could explain the cross-reactivity only in a third of cases. Both those with wheat and grass allergies were 
positive in the CD-sens, with stimulation of wheat and grass. There was a trend to higher CD-sens values to wheat in the WA 
group compared to the non-WA.  Children in the wheat group had generally poorer quality of life than children in the grass 
group. The parents to the children in the wheat group experienced a significantly poorer quality of life compared with grass 
group. Children and parents in the grass group had a good agreement in the quality of life questionnaire but not for all 
domains in the wheat group. 
Conclusion 
Based on the results of this thesis half of the children with a doctor´s diagnosed wheat allergy seem to avoid wheat 
unnecessarily. The reason for this may be that they developed tolerance over time or that the individual is falsely diagnosed 
due to cross-reactivity between wheat and grass pollen. We have shown that analysing IgE- ab against gliadins and glutenins 
increases the diagnostic accuracy for wheat allergy and distinguishes between those with wheat allergies from those with 
IgE-ab to wheat due to cross-reactivity with grass. CD-sens with wheat extract has a limited value -but may be useful when 
individual wheat proteins are used for stimulation. Quality of life was impaired in families with wheat-allergic children 
compared to families with grass-allergic individuals. This further strengthens the fact that the diagnosis of wheat allergy 
needs to be improved to avoid elimination diet and concerns about food allergy. 
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1  INTRODUCTION 
Wheat is one of the six most common food allergies in children. Together with hen’s egg, cow’s milk, 
peanut, fish, soy and nuts it represents over 80 % of all food allergies in children (1, 2). 
Wheat is a very common food throughout the whole world and is introduced into our diet early on in life, 
either through breast-feeding or when the infant begins to eat other food at approximately 5 months of age 
(3, 4). The extensive use of wheat and related cereals in our daily diet makes cereal-associated allergies a 
particularly serious problem. Ingestion of wheat allergens can lead to a variety of clinical manifestations, 
including cutaneous, gastrointestinal and respiratory symptoms.  The symptoms can vary from mild to life 
threatening. Patients with a medical history of food allergy (FA) could be subject to further examinations. 
The methods commonly used in clinical practice to diagnose WA include an in vivo skin prick test (SPT) 
and/or in vitro serological determination of wheat-specific IgE-ab. In contrast to the situation with eggs, milk 
and peanuts, these tests are of limited value in diagnosing clinically relevant W (5). The correlation between 
the outcome of an oral wheat challenge (the gold standard) and serum levels of wheat-specific IgE-ab is 
poor (4, 6, 7), so there are many false positive tests. One reason for this may be that wheat, since it is a 
grass from the Poaceae family, contains several allergenic proteins, many of which are known to cross-
reactivity with grass pollen allergens as (8, 9). As a consequence of the false positive tests, too many 
patients are classified as being wheat allergic and given dietary restrictions. An oral challenge test is 
recommended to confirm WA. This is a procedure which is time consuming, has to be performed by trained 
personnel and constitutes a risk for the patients. Recently other diagnostic methods, such as component 
resolved diagnostics (CRD) and basophil allergen threshold sensitivity (CD-sens) has been developed and 
have shown promising results (10, 11).  Since wheat is such a commonly used food, a food restriction poses 
severe disruptions both for the affected individual as well as for the family. This has been shown for other 
types of FA (12-14).  
The aim of this thesis is to study different diagnostic methods and their ability to identify truly wheat allergic 
patients.  
Furthermore we studied the impact of the diagnose of wheat and grass allergy by documenting the quality 
of life (QoL). The terminology used in this thesis adheres to the recommended nomenclature for allergy 
from WAO 2003 (15, 16). 
1.1 FOOD ALLERGY 
Prevalence 
FA in children is a common disease in a global perspective. The prevalence of food allergies is reported to be 
up to 6% of young children and 3%–4% of adults (1, 2). However there is a difference in the FA prevalence 
reported by the patients or their parents compared to confirmed FA by oral food challenge (2, 17, 18). The 
reported prevalence vary in different study groups, in different geographic regions and due to variations in 
diet (18). Furthermore the definitions of allergy also vary, which is also an explanation for variation in 
prevalence. FA in children is a significant public health concern, manifesting through both an increasing 
prevalence and a changing pattern in the disease expression (19). In recent generations, FA starts earlier in 
life, with greater severity and persistence into later ages (20). Recently published meta-analysis found a 
marked heterogeneity in prevalence numbers due to differences in the definition and methodology used. 
High prevalence numbers was reported for Western and Northern Europe. Boys have a higher risk of 
developing food allergy and a family history of atopy and atopic dermatitis are also well known risk factors 
(21).  
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The term allergy was presented about a hundred years ago as being a change in an individual’s immune 
systems reactivity (22). Food allergy is defined as an adverse health effect arising from a specific immune 
response that occurs reproducibly on exposure to a given food. Food allergens are defined as those 
specific components of food or ingredients within food (typically proteins, but sometimes also 
carbohydrates) that are recognized by allergen-specific immune cells and elicit specific immunologic 
reactions, resulting in characteristic symptoms. Some allergens (most often from fruits and vegetables) 
cause allergic reactions primarily if eaten raw. 
Classification of food intolerance 
The terminology used in this thesis adheres to the recommended nomenclature for allergy from WAO 
2003 (15, 16).Reactions to food can be classified as toxic or nontoxic reactions. Toxic reactions can occur 
when foods are contaminated by toxins, or by viruses. Nontoxic reactions are categorized further as 
immune-mediated or non–immune-mediated (Fig 1) (23). 
                   
 
Fig 1.Types of adverse reactions to food.  Adapted from R Valenta (23). 
Non-immune mediated adverse reactions are termed food intolerances and include for instance lactose 
tolerance. Immune mediated reactions can be divided into IgE-ab mediated and non-IgE-ab mediated 
conditions such as food protein-induced enteropathy, eosinophilic GI disorders and food-induced allergic 
contact dermatitis. 
Hypersensitivities involving the adaptive immune system can be subdivided into 4 categories (type I–IV). 
Type I reactions are associated with IgE-ab antibodies against food allergens. There is firm evidence for 
an involvement of IgG antibodies in type II or type III reactions in immune-mediated adverse reactions to 
food, whereas type IV reactions involve T cells (celiac disease).  
We have in this thesis specifically examined IgE-ab mediated allergy in children and many of them have 
symptoms from different organ systems (Table 1). About two hundred different foods have been 
reported to induce IgE-ab mediated reactions. The most commonly associated foods include cow’s milk, 
hen’s egg, soy, wheat, tree nuts, peanut and fish (24, 25). 
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 Immediate symptoms Delayed symptoms 
 
Cutaneous Erythema Erythema 
 Pruritus Flushing 
 Urticaria Pruritus 
 Morbilliform eruption Morbilliform eruption 
 Angioedema Angioedema 
  Eczematous rash 
 
Ocular Pruritus Pruritus 
 Conjunctival erythema Conjunctival erythema 
 Tearing Tearing 
 Periorbital edema Periorbital edema 
 
Upper respiratory Nasal congestion  
 Pruritus  
 Rhinorrhea  
 Sneezing  
 Laryngeal edema  
 Hoarseness  
 Dry staccato cough  
 
Lower respiratory Cough Cough, dyspnea, and wheezing 
 Chest tightness  
 Dyspnea  
 Wheezing  
 Intercostal retractions  
 Accessory muscle use  
 
GI (oral) Angioedema of the lips, 
tongue, or palate 
 
 Oral pruritus  
 Tongue swelling  
 
GI (lower) Nausea Nausea 
 Colicky abdominal pain Abdominal pain 
 Reflux Reflux 
 Vomiting Vomiting 
 Diarrhea Diarrhea 
  Hematochezia 
  Irritability and food refusal with 
 weight loss (young children)  
 
Cardiovascular Tachycardia (occasionally  
bradycardia in anaphylaxis) 
 
 Hypotension  
 Dizziness  
 Fainting  
 Loss of consciousness  
 
Miscellaneous Uterine contractions  
 Sense of “impending doom”  
 
          Table 1. Symptoms of food-induced allergic reactions 
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A diagnose of food allergy leads to recommendations of food avoidance which influences the daily life 
for patients and their families (26, 27). Naturally this affects their quality of life and furthermore may it 
increase the cost for the society.  
1.2 IMMUNOLOGY 
 OVERVIEW 1.2.1
The immune system’s main function is to protect the body from infection and when an immune cell 
identifies an affected cell or intruder it does so by reacting to an antigen. These can be relatively 
harmless, like grass pollen, or harmful like an invasive bacteria (28, 29).  
An allergic reaction is the result of that the immune system reacts to a harmless antigen and initiates an 
immune response to this antigen, which is called an allergen (30). 
                                           
Fig 2. Hematopoesis.  
Hematopoietic stem cells produce cells in blood and lymph. Adapted from Biology of the Immune System, 
JAMA 278. 
The main functions of the different immune cells involved in allergic reactions are:  
Granulocytes: There are three types of granulocytes; neutrophils, eosinophils and basophils.  Neutrophils 
have the capability to phagocytose bacteria and aggregate in vast numbers around a pathogen. 
Eosinophils and basophils are important in the defence against parasites. They do so by releasing pro-
inflammatory mediators, which also make them important in initiating an allergic process.   
Basophils show expression of the activating receptor for IgE-ab (FcεRI), production of Th2 stimulating 
cytokine and histamine release. Basophils are found in circulation and furthermore they are relatively 
short lived.  Basophils play a role in the delayed hypersensitivity reaction since after the acute phase they  
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infiltrate the affected organ (lung, upper respiratory tract, skin). Mast cells reside in tissues close to surfaces 
like the epithelium and blood vessels and are one of the major components in the IgE-ab mediated allergic 
reaction. 
Dentritic cells are the most important antigen presenting cells.      
T lymphocytes are divided in two types, cytotoxic T-cells and T-helper cells. They play a pivotal role in 
identifying and killing infected or abnormal cells. They can avoid adverse immune activation, maintain 
tolerance and prevent immune responses to the body’s own cells and antigens. 
B lymphocytes, or B-cells, have a specific role to produce antibodies. If activated, the B-cell can multiply and 
produce huge numbers of antibodies (29). An antibody structurally comprises two elements, two identical 
light chains and two identical heavy chains see figure 3. The antibody, or immunoglobulin, has two 
components with different functionality, the Fab and the Fc component. The highly variable part is the Fab 
component which also is the antigen binding part of the antibody (28). This part is unique for each antibody. 
The Fc component is the same for all antibodies of a given class and they bind to Fc receptors on the surface 
of different immune cells.  
                                       
Fig 3. Structure of IgE-ab.  Modified from Delves P.J (28). 
The B-cell receptor consists of an Ig molecule anchored to the cell’s surface. CH = heavy chain constant 
region; CL = light chain constant region; Fab = antigen-binding fragment; Fc = crystallizable fragment; Lκ or λ 
= 2 types of light chains; VH = heavy chain variable region; VL = light chain variable region. 
Five classes of antibodies are known, IgA, IgD, IgG, IgE-ab and IgM. Each class exerts its own specific function 
in the immune system.     
      The IgE-ab antibody 
The pathological role of IgE-ab in allergy and asthma is now well-established; the normal beneficial function 
remains unclear. It has been speculated that the primary purpose of IgE-ab could be in the defence against 
parasitic infections.  
Given the ability of IgE-ab to detect minute amounts of foreign proteins in combination with its ability to 
activate other parts of the immune system, it appears much more probable that it may have a “gatekeeper” 
function to be the first to sound the alarm when a foreign protein enters the body, activating and recruiting 
other antibodies and cells that can attack and defeat the intruder (31). 
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 IMMUNOLOGICAL BACKGROUND TO ALLERGIC DISEASE 1.2.2
If the immune system reacts to an antigen which is harmless then an allergic disease may develop. 
Allergic sensitization 
Allergen contact via the gastrointestinal tract (32), via the respiratory tract (33), and probably via the skin 
induces IgE-ab production (primary sensitization) (23, 34). Repeated allergen contact activates allergen-
specific T cells and induces IgE-ab responses during the secondary immune response. Factors that affect 
the epithelial barrier and the extent to which allergens are digested or degraded are important for 
primary sensitization and boosting of secondary immune responses. 
The allergic reaction can be divided in an early phase, or immediate, type I reaction and a late phase type 
I reaction. In the early phase reaction symptoms develop very quickly, within minutes or even seconds. 
The mechanism behind this is degranulation of mast cells and the release of histamine, proteases and 
leukotrienes by basophils, causing inflammation and clinical symptoms.  
The late phase allergic reaction develops 8-12 hours after the triggering event and is caused by the 
release of cytotoxic molecules from lymphocytes and eosinophils that have been recruited from the 
blood into the allergic site (35). This late phase type I reaction should not be mistaken for a delayed 
hypersensitivity reaction, also known as type IV allergic reaction, which normally develops later, after 2-3 
days (23).  
Tolerance 
Many allergic children develop tolerance with increasing age to foods such as egg, milk and wheat while 
allergies to peanut and fish tend to persist (36, 37). The higher the IgE-ab level to the food is, the less 
likely it is that the patient will develop tolerance (25, 38). How fast tolerance develops varies between 
individuals and allergies and can continue until adolescence. A decline in IgE-ab levels can be an early 
indication of tolerance development, however it is not always predictive of a true tolerance 
development since if the individual is not exposed to the allergen then the IgE-ab levels will decline (36, 
37, 39). 
The reasons why some develop tolerance and others do not are not well understood but several theories 
have been proposed. The underlying immunological changes include a reduction in allergen-specific IgE-
ab production, decreased basophil activation, increased allergen specific IgG4 and induction of Treg cells 
(40-42).  
1.3 WHEAT ALLERGY 
 HISTORY 1.3.1
Wheat belongs to the Poaceae family also referred to as true grasses which is a large and ubiquitous 
group of flowering plants. Wheat is believed to stem from the Middle East and already 9000 years ago 
primitive wheat was cultivated by humans in eastern Iraq. 7000 years ago it was cultivated in Egypt, 
China, India and even England. 
The importance of wheat throughout history is illustrated in many ways; by ancient descriptions from 
China how to grow wheat, dating back almost 5000 years and the fact that it is mentioned in the Bible. 
Socrates said: “No man qualifies as a statesman who is entirely ignorant on the problems of wheat” and 
a more recent quotation is from President Hoover: “The first word in war is spoken by guns, the last 
word has always been spoken by bread.”   
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Wheat is grown on more land area worldwide than any other crop and is currently farmed in all parts of 
the world. Wheat is easy to grow, transport, store and can be processed into a variety of foods. Wheat 
contains gluten protein, a feature that is utilized in getting dough to rise because of the small gluten 
vesicles containing carbon dioxide that are formed during fermentation. Wheat is a component of 
numerous foods. Breads, cookies, cakes, pancakes, noodles, pasta, ice creams and many breakfast 
cereals contain wheat and it is also used as a thickener in many foods like soups and sauces.   
The structure of the wheat grain 
 Wheat grains are normally between 5 and 9 mm in length, ovally shaped and weighs between 35 and 
50mg. The grains have commonly a red colour and have several compartments as shown in the figure 5. 
The protein content varies between 7-17 %. 
                                                       
Figure 5. Composition of the wheat grain. 
Endosperm is a tissue produced inside the seeds.  Inside each cell are found granules of starch and these 
are surrounded by a clear glassy protein. It is this protein, gluten, when wetted that causes the stickiness 
and structure of dough. It is this curious combination of properties of the protein that makes wheat flour 
unique amongst the grains and suitable for bread making. 
  CLASIFICATION OF WHEAT PROTEINS 1.3.2
Wheat proteins are categorized into four fractions on the basis of their solubility in a series of solvents: 
water (albumins), dilute salt solutions (globulins), aqueous alcohol (gliadins), and dilute alkali or acid 
(glutenins). The albumins and globulins are mainly structural proteins and metabolically active enzymes. 
The water/salt-insoluble gliadins and glutenins, together known as prolamins or gluten, are the major 
storage proteins of the wheat grain (Fig 6). 
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Fig 6. Classification of wheat proteins. Adapted from Sigrid Sjölander, Uppsala.  
Albumins and globulins 
Alfa-amylase inhibitors are the most important wheat proteins contributing to bakers' asthma. Profilins 
are proteins that are found in all eukaryotic cells and constitute a key component in the cells 
cytoskeleton.  They consist of a large portion of the class 2 allergens (mainly seen in adults and develops 
as a consequence of an allergic sensitization to inhalant allergens) and frequently show cross-reactivity 
between pollen and food (43). 
Gliadins and glutenins 
The prolamins share a great degree of sequence and structural homology with each other and with the 
corresponding proteins in rye and barley. They can be divided into two fractions according to their 
solubility in aqueous alcohols: the soluble gliadins and the insoluble glutenins. Gliadins are monomeric 
proteins and can be classified according to their primary structures into the α/β-, γ- and ω-type. Based 
on primary structure, glutenin subunits have been divided into the high-molecular-weight (HMW) 
subunits) and low-molecular-weight (LMW) subunits (44). 
Other wheat proteins 
Glycoproteins are proteins that contain oligosaccharide chains (glycans) and are often important integral 
membrane proteins. Water-soluble glycoproteins that are 10 to 70 kDa in size have been identified as a 
class 1 allergen (the sensitization process occurs in the gastrointestinal tract) (43). 
Wheat protein hydrolysates are peptides derived from wheat through proteolysis. These hydrolysates 
can create allergens of wheat proteins that previously did not exist. Such hydrolyzed wheat proteins is 
used as an additive in foods and cosmetics. 
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 CLINICAL MANIFESTATION OF GLUTEN RELATED DISORDERS 1.3.3
In 2011 in London, 15 leading experts met and proposed an on new nomenclature and classification of 
gluten-related disorders (Figure 7) (45) . 
                       
 
 
Fig 7. Nomenclature and classification of gluten-related disorders. Modified from A Sapone (45). 
 WHEAT ALLERGY CLASSIFICATION 1.3.4
Depending on how the individual is exposed to the allergen WA can present itself in different ways; 
  -Respiratory allergy (Baker´s or occupational asthma and rhinitis) 
            - IgE-ab mediated food allergy (FA), symptoms from the skin, GI or the respiratory tract 
            -Wheat-dependent exercise-induced anaphylaxis (WDEIA) 
             -Contact urticaria 
Baker´s asthma  
Baker’s asthma is an occupational disease affecting bakery workers globally (46) . It is caused by 
repeated inhalation of the allergen and the annual incidence of disease ranges between 1 and 10 cases 
 22 
per 1000 bakery workers. It is a severe occupational hazard and wheat flour is the leading causative 
agent for this allergy. 
IgE-ab mediated WA 
IgE-ab mediated WA is more common in children than in adults since most children develop tolerance, 
similar to what is seen with egg or milk allergy (39, 47, 48). However, sensitization as measured by IgE-ab 
is more prevalent in adults. WA patients present, if wheat is consumed, with characteristic IgE-ab 
mediated immediate symptoms like urticaria, angioedema, bronchial obstruction, and nausea and 
abdominal pain, or even systemic anaphylaxis (49, 50). Delayed hypersensitivity symptoms are also seen, 
which present after about 24 hours and comprise gastrointestinal symptoms and worsening of atopic 
dermatitis (51). WA in children can elicit all the symptoms associated with FA (Table 1). 
Wheat-dependent, exercise-induced anaphylaxis (WDEIA)  
WDEIA is an allergic reaction caused by ingesting wheat followed by physical exercise. Since both the 
amount ingested and the extent of exercise may vary between individuals, WDEIA poses a diagnostic 
challenge. Furthermore, other factors like NSAIDs (Non-steroidal anti-inflammatory drugs) such as aspirin 
have been reported to trigger the reaction (52, 53). As the name implies; wheat is the most common 
agent causing WDEIA. It has also been reported that in some cases more than one trigger is needed to 
provoke the reaction e.g. exercise and cold stimulation. The reaction lasts several hours and symptoms 
can vary significantly and can include local or generalized urticaria, dyspnea, hypotension, collapse, and 
shock (49). 
Contact urticaria  
Recent studies have found an association between contact urticarial and sensitization to hydrolysed 
wheat protein (HWP). The fragmentation of gluten is done in order to increase the solubility and the 
process is known as hydrolysation.  This food product is referred to as HWP and has shown to be 
allergenic. HWP can cause the same reactions as gluten ranging from contact urticaria  through 
cosmetics (54-57) to anaphylaxis when it is used in food or food products (58). Even food-dependent 
exercise-induced anaphylaxis (FDEIA) has been reported.  
  WHEAT ALLEGY PREVALENCE 1.3.5
WA and sensitization to wheat is common, but the prevalence varies significantly. Even in children who 
have been exclusively breast-fed, sensitization may take place.  The heterogeneity between studies is 
high (59). Several factors can explain this, for example there is big discrepancy between self-reported WA 
and standardized methods. Nwaru reports an overall pooled estimate of WA of 3.6% (95% CI 3.0–4.2) for 
lifetime self-reported prevalence, 1.5% (95% CI 1.3–1.8) for point self-reported prevalence, 0.7% (95% CI 
0.4–1.0) for SPT positivity, 3.9 (95% CI 3.4–4.4) for specific IgE-ab positivity, 0.1% (95% CI 0.01–0.2) for 
food challenge positivity, and 0.3% (95% CI 0.02–0.6) for food challenge or history of WA (59) . Another 
factor to consider is at what age the investigations are done as tolerance develops in as much as 65-80 % 
of patients. Published data also reports geographical differences where WA is more frequent in Northern 
Europe compared to Southern Europe (60). In a population-based birth cohort in Stockholm, the 
prevalence of sensitization to wheat in 2336 4-year-old children was reported to be 4% (61, 62). 
Wheat allergy - natural history 
Published data indicate that 65-80 % of children with an allergy towards cow's milk, wheat, soya and egg, 
develop tolerance. For peanut and tree nuts the corresponding figure is 10-20 % (42).  
Kotaniemi-Syrjanen et al recently reported on 28 children that showed clinical tolerance in in 59%, 69%, 
84%, and 96% by ages 4, 6, 10, and 16 years, respectively (39). A US study followed 103 children with a 
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history of reactions to wheat and sensitization to wheat (47). The percentage of children with tolerance 
was 29% by 4 years, 56% by 8 years, and 65% by 12 years. In this study the median age by which the 
patients WA were resolved was 6.5 years. Only a small fraction of the patients had a persistence of their 
WA into adolescence. Czaja-Bulsa et al reported that the mean age of tolerance was 69.5 months  in 
their WA cohort  (48). The rates of resolution were 20% by the age of 4 years, 52% by the age of 8 years, 
and 66% by 12 years, and 76% by 18 years.  
1.4 DIAGNOSTIC METHODS IN WHEAT ALLERGY 
Detailed clinical history is essential for the diagnosis of FA and EAACI has recently issued guidelines 
regarding FA focusing on diagnosis and management (63) . A clinical history of FA includes inducing 
allergens, timing and chronicity, symptoms, severity and signs, known risk (co)factors, family history, 
coexisting medical problems including other allergic diseases. It is recommended to use standardized 
questionnaires to identify these factors. 
Different tests and procedures should be used to identify allergens: elimination diet, skin prick test (SPT), 
IgE-ab measurements in serum, oral food challenge (OFC) and component resolved diagnostics (CRD) as 
well as CD-sens. 
  ELIMINATIONS DIET 1.4.1
An initial strategy when treating FA patients is to avoid the suspected food. The decision which food to 
avoid is usually based on the patient’s rapport and the result of allergy tests (SPTs and/or IgE-ab). Only 
one food at a time should be avoided for a period of 2-4 weeks. If no relief of symptoms is noted it is 
unlikely that the patient is allergic to that specific food. If, on the other hand a significant reduction in 
symptoms occur the avoidance should be maintained until a provocation test is done. 
 SKIN PRICK TEST (SPT) 1.4.2
Wheat is introduced in the skin to confirm whether the patient is sensitized or not. The test is deemed as 
positive if the diameter of the wheel exceeds 3 mm (64-67). The size of the wheal correlates relatively 
well with the likelihood of WA (66, 68). The benefit of the test is that it is easy to perform, relatively 
painless and gives a quick readout.  Several factors influence the quality of the test like the skill of the 
person applying the test, the type of allergen used, the age of the patient, antihistamine intake, 
pregnancy and skin reactivity (65). Different batches of commercially available allergen extracts can also 
vary in the protein content which also will influence the result (69-71). Adverse reactions in children have 
been described (72).  
  IgE-AB MEASUREMENTS IN SERUM 1.4.3
IgE-ab assays detect and measure circulating IgE-ab that bind to specific allergens in a patient´s serum. 
Several commercial tests are available and the ImmunoCAP test is mostly used in Sweden. The read out 
unit is kUA /L (kilo international units of allergen specific antibodies per litre). One international unit 
corresponds to 2.42 ng of IgE-ab and the lower limit of detection is 0.1 kUA /L (ImmunoCAP).There is no 
interference by anti-histamines or dermatitis, and furthermore several anti IgE-ab can be tested in one 
sample and the test is standardized (68, 73). The drawback is that venipuncture is needed and the 
physician receives the result the following days. SPT and serum IgE tests have similar properties and are 
sensitive.  Similar to SPT the result should be interpreted with caution especially when it comes to WA. 
Sampson et al (5) reported specific threshold levels for a number of major food allergens in a pediatric 
population, including wheat. The 95 % decision point for wheat was > 100 kUA /L. The relative incapacity 
of the IgE-ab tests might be explained by the fact that extract based tests lack important allergens 
primarily from the gliadin fraction since those are insoluble.  
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 COMPONENT RESOLVED DIAGNOSTICS 1.4.4
CRD, also known as molecular-based allergy diagnosis, involves using purified, native or recombinant 
allergen to detect IgE-ab sensitization to different proteins in an allergen source (74, 75). The reason for 
utilizing this technique is that an allergen, like wheat, contains many different proteins which can trigger 
an allergic reaction, and hence using single proteins to quantify the IgE-ab enables a more specific 
answer to what is causing the symptoms. 
The individual allergen components are named according to the system developed by Linné. The latin 
name of wheat is Triticum aestivum and the principle by which the components are named is using the 
first three letters in the genus name followed by the first letter of the species name and finally a number 
is added for the different allergens identified (i.e. Tri a 1).  
The International Union of Immunological Societies Allergen Nomenclature Subcommittee Database has 
21 proteins listed as allergens for wheat out of which 9 are linked to FA (www.allergen.org).  
Wheat contains many different proteins some of which belong to protein families found also in other 
plants, such as the closely related grasses (44). Hence an IgE-ab antibody can bind to a protein of another 
source than the original sensitizing protein (primary allergen) and elicit an immune response. This is 
known as cross reactivity.   
The wheat-specific allergen components can be divided in two groups, the water/salt soluble fraction 
containing albumins/globulins and the water/salt insoluble fraction consisting of glutenins and gliadins    
(Fig 6). 
Albumins and Globulins 
Profilins are known to be the one of the major allergen present in tree, grass, and weed pollen. About 
20% of individuals allergic to pollen are sensitized to profilin and it has reported that the IgE-ab 
antibodies to pollen profilins are highly cross-reactive to profilins in vegetable. Patients often become 
sensitized to the inhaled pollen at first. If the person then ingests raw fruits or vegetables containing 
profilins, they can experience oral and pharyngeal symptoms, i.e., the pollen-FA or oral allergy syndrome. 
The profilins are highly heat labile, susceptible to enzymatic degradation.  
Alpha amylase inhibitors are well-known allergens in Baker’s asthma (76)  and they seem to play a role 
in ingested WA as well (77, 78). Recently Mäkelä (79) showed that sensitization to alpha amylase 
inhibitors seem to distinguishing children with immediate reactions from non-reactors. 
Lipid transfer protein in wheat and other cereals have also been identified as food allergens in several 
studies (78). Pastorello et al identified LTP as a major allergen in wheat FA in Italian patients (76, 78). 
Glutenins and Gliadins  
Gluten proteins are major anti IgE-ab in triggering celiac disease as well as IgE mediated WA (80). 
Wheat ω-5 gliadin has been identified as the major allergen in wheat-dependent, exercise-induced 
anaphylaxis (WDEIA) (4, 49, 81). Several studies have shown ω-5 gliadin to be a significant allergen in 
young children with immediate reactions to ingested wheat (4, 78, 81, 82). 
Hoffmann found high prevalence of specific IgE-ab to omega 5-gliadin, alfa, beta, gamma gliadin and high   
low molecular weight (HMW) glutenin in patients with WDEIA  (83). Pastorello et al reported both alpha 
and gamma gliadins to be of importance in WA (78). Mäkelä et al reported alpha gliadin to be the best 
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allergen in the gluten fraction in terms of both sensitivity and specificity with regards to immediate 
reactions to wheat (79).  
Both high and low molecular weight glutenin seem to play a role in WA. Baar et al showed that 80% of 
WA patients had sensitization to LMW glutenin (84). LMW-glutenin has been reported as major allergen 
in patients with GI symptoms after ingestion of wheat (77). Takahashi et al reported HMW glutenin to be 
of significance in Japanese patients diagnosed with WDEIA (85). Mäkelä et al reported on the importance 
of HMW glutenin in children with immediate reactions to ingested wheat (79). 
Cross-Reactive Carbohydrate Determinants (CCD) 
Cross-reactive carbohydrate determinants (CCD) are protein-linked carbohydrate structures known to be 
related to allergen cross-reactivity. Their biological role and activity has been questioned and normally 
diagnostic results caused by CCDs are therefore regarded as false positives. 
 CD-SENS 1.4.5
Basophil activation test (BAT) is an in vitro test measuring the activation of basophils upon stimulation 
with allergens (86-88). The activation can be measured in two different ways, either by investigating 
secretion of mediators from basophils (mediator release assay) or by detecting expression of cellular 
markers after stimulation (flow cytometric assays). The most commonly used mediator release assays, 
the histamine release test, measures the release of histamine based on the fact that the granule of 
basophiles contain histamine. The activation of the basophils is calculated as the histamine released as a 
percentage of the total histamine content (89).  
In flow cytometric assays the evaluation of basophil activation is measured through the detection of 
unique membrane markers expressed only after activation, such as CD63, or through the increase of the 
expression of CD203c (89, 90). 
In a non-activated basophil CD63 is only found in the intracellular granules and only low levels of CD203c 
is expressed on the cell surface (Fig 8) (90, 91). When activated granules move to the cell membrane and 
fuse, CD 63 will be presented on the cell surface. CD203c is rapidly up-regulated when the basophil is 
activated. 
The majority of patients are responsive to activation of their basophils. Published reports indicate that 
between 80-90 % are responsive (91), implying that as many as 10-20% are non-responsive. 
In this thesis we have used a method known as the basophil allergen sensitivity test (CD-sens) (92). It 
measures the lowest allergen dose at which a 50 % activation of CD63 of the basophils takes place. The 
lower the level of allergen is the higher the level of allergen sensitivity.  
Published studies indicate a relative good correlation between the outcomes of SPT, IgE-ab levels and 
CD-sens in allergic rhinitis. Pignatti et al report that for FA patients the agreement (positive/positive and 
negative/negative) between single BAT and SPT was 78.5% and between single BAT and IgE-ab 78.3% 
(93). 
Glaumann et al shows a good correlation  between CD-sens and OFC for peanut allergy  (10) . 
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                                             Fig 8. Activation of basophils. With permission from Anna Nopp (91). 
 
 ORAL FOOD CHALLENGE 1.4.6
To confirm a diagnosis of an IgE-mediated FA it is often necessary to perform a food challenge test (94). 
It is used to either confirm allergy or to demonstrate tolerance. Patients are given increasing amounts of 
the allergen in question every 20-30 minutes. If a reaction occurs the challenge is discontinued (95). A 
scoring system is used to judge the severity of symptoms (95). The result guides the recommendations 
given to the patient regarding safe dietary expansion or appropriate allergen avoidance. 
There are several different types of food challenge tests that may be clinically indicated: open, single-
blind, double-blind and/or placebo-controlled. Open food challenge (OFC) is unmasked, non-blinded 
feeding that is usually done if symptoms such as asthma or urticaria are anticipated (96, 97). OFC is a 
cost-efficient procedure that saves time and resources (94, 97). In daily practice a non-blinded open food 
challenge (OFC) is used since it is less time consuming and the food is ingested in its natural form.  
Placebo-controlled challenges may be administered in both single-blind and double-blind fashion (97). 
The gold standard is the double-blind placebo-controlled food challenge (DBPCFC) (95) which should be 
used when symptoms are subjective or if the symptoms are atypical or if the patient/parents or health 
care personnel are anxious (95). Furthermore it is the preferred method in research and for selected 
cases in clinical practice (94, 97). 
The challenge food is mixed with the vehicle and administered with increasing dose every 15-30 minutes. 
This time interval is chosen because most acute reactions occur within this time frame; in patients with a 
previous history of severe reactions, a lower starting dose is recommended. Initial dose is guided mainly 
by clinical assessment of risk of reaction and type of FA. 
 OFC is usually started with 0.1% to 1% of the planned total dose of challenge food. The European 
Academy of Allergy and Clinical Immunology proposed an initial doses of 100 mg wheat for OFC (71).The 
most sensitive patients may react at the first 10 mg to 100 mg dose of the challenge food according to 
published studies (94, 95, 98). 
  27 
All oral food challenges should be performed under strict medical supervision with emergency support 
directly available and if there is risk of a severe reaction then intensive care support must be 
immediately available. The OFC is negative if the patient tolerates the entire challenge, including the 
observation period 1-2 hours. In case of a positive OFC, the treated patient should remain under 
observation after symptoms have resolved for up to 4 hours. 
1.5 GRASS ALLERGY 
Grasses covers a substantial part of the earth’s landmass and their pollen is one of the major causes of 
IgE-ab mediated allergic disease (99). Pollen that gives rise to allergic symptoms are present in the air in 
northern Europe at least 6 months every year. It causes severe implications for children affected, and 
interferes in many aspects of their daily lives both physical, practical and emotional (100). 
Amongst the grasses, timothy (Phleum Pratense) is one of the most common species to elicit an IgE 
sensitization. The proteins of timothy has been examined and characterized and as a result a number of 
allergen components have been identified. Some of which are” species specific allergens” like Phl p 1 and 
Phl p 5 whilst the profilin Phl p 12 and the calcium-binding protein Phl p 7 are the principal cross-reactive 
components (101, 102).  
Allergy to grass pollen is reported to increase amongst children worldwide and it has also been 
demonstrated that Phl p1 is the most relevant sensitizing allergen detectable at all ages and at all levels 
of timothy grass pollen-specific IgE-ab. In contrast, Phl p 5 becomes increasingly more important with the 
increase of patients' age and with grass pollen IgE-ab levels. 
 Since both wheat and timothy are members of the Poaceae family they share similar proteins. This is the 
reason why co-occurrence of IgE-ab to timothy pollen and wheat are common (9). It is uncertain how 
frequent sensitization to wheat is among grass pollen allergic patients. Furthermore it needs to be 
elucidated which allergens cause the serological cross reactivity. 
Constantin et al reported that 65% of the patients with grass pollen allergy had false-positive IgE-ab test 
results to wheat (103). In a study of young asthmatics sensitized to timothy. Patelis found that 17% were 
also sensitized to wheat but only 7% reported wheat hypersensitivity (104). 
1.6 HEALTH RELATED QUALITY OF LIFE (HRQOL) 
DunnGalvin has defined HRQL as the patient´s perception of the effects of the consequences of a specific 
disease or the use of a certain treatment on different aspects of his/her life, particularly the 
consequences for the patient´s physical, emotional and social wellbeing (105). 
In order to evaluate an individual’s QoL, validated instruments are used. These are often questionnaires 
rating health and different domains, but may also be a graded scale or a visual analogue scale.  
Most instruments define HRQoL with two main domains: physical function and psychosocial function. 
Since Qol comprises many different aspects, two different types of HRQoL are used: the general 
instruments (generic) or disease-specific instruments. 
 Generic instruments asses the general health and can be used to compare different conditions or 
against general population. Disease specific instruments can be used for specific conditions and 
questions are specific for that disease. 
It has been reported that children suffering from food allergy show lower HRQL scores compared to non-
allergic children (106). Even families to patients are affected which was demonstrated by Mikkelsen et al 
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(107). They studied HRQL among children with cow’s milk allergy and found that affected families 
experienced higher stress on their daily lives and nutrition concerns compared to control families (107). 
Protudjer et al (108) recently reported the benefit of using disease specific questionnaires since such 
instruments can elucidate the impact on QoL which a generic instrument cannot. Furthermore a disease 
specific questionnaire can distinguish between food allergic impact and impact from comorbidity (109) . 
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2 OBJECTIVES 
2.1 GENERAL OBJECTIVES 
The general objective of this thesis was to characterize wheat allergy in children clinically and serologically, 
and investigate cross reactivity between wheat and grass allergy.  
2.2 SPECIFIC OBJECTIVES 
The specific objectives were: 
 
 To determine what proportion of children with a medical history of wheat allergy and IgE-ab 
antibodies to wheat exhibit clinical symptoms in response to an oral challenge with wheat. 
 
 To determine the utility of IgE-ab antibodies to wheat and wheat- and grass-allergen 
components to predict allergic symptoms in children with a doctor´s diagnose of wheat or 
grass allergy. 
 
 To determine whether basophils stimulated with wheat, omega-5-gliadin or timothy grass 
pollen can predict allergic symptoms in individuals sensitized to wheat. 
 
 To analyse possible serological cross-reactivities in children with a doctor´s diagnose of 
wheat and grass allergy and to compare the quality of life of these two groups of children. 
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3 MATERIAL AND METHODS 
3.1 STUDY GROUPS AND STUDY DESIGN 
This thesis includes subjects from two different groups. The first two papers (I and II) are based on subjects 
with doctor´s diagnosed wheat allergy from Astrid Lindgren's Children's and Sachs' Children´s and Youth 
Hospital, Stockholm, Sweden (wheat group)  (Fig 9).  Paper III includes subjects with doctor´s diagnosed 
grass pollen allergy (grass group). Paper IV includes patients from both groups. 
Figure 9 is describe included and excluded individuals from the two study groups  and their representation 
in the different papers. 
Astrid Lindgren's Children's and Sachs' Children´s and Youth Hospital are two children´s hospital in the 
Stockholm Area. The Allergy departments have food allergy units diagnosing and treating children with 
moderate to severe food allergy. 
    
 
 
Fig 9. The studied wheat and grass group in relation to the four different articles in the thesis. 
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 Wheat group 3.1.1
To identify patients with wheat allergy the code Z91.0E according the International Classification of 
Disease, Tenth Revision (ICD-10) were searched for at all children´s hospital hospitals in Stockholm;  Sachs' 
Children´s and Youth Hospital and Astrid Lindgren´s Children’s Hospitals Solna (ALB) and Huddinge and in all 
paediatric open-care units (n=25) in the Stockholm area between 2008-2012.  All records with the diagnosis 
Z 91.0E had to be reviewed in detail as this diagnosis accounts for all food allergies but milk, egg, nuts, 
peanuts, and fish that have their own diagnosis codes. 
Paediatric patients who have received the diagnostic code Z 91.0 E and who fulfil the criteria for inclusion 
without demonstrating any of the criteria for exclusion were contacted and asked to participate. 
Eligible patients were contacted by telephone and were given a verbal description of the study. Those 
interested in participating received written information and were later contacted again by telephone to ask 
if they still wished to participate. Children, who were willing to participate in the study and who mailed a 
written parental consent were scheduled for a visit.  All procedures, blood samples and oral food 
challenges (OFC), were carried out during three visits (Table 2) at the Lung-Allergy Department of Astrid 
Lindgren´s Children’s Hospital, Karolinska University Hospital in Solna.  
Inclusion criteria:  
- Doctors’ diagnosis of wheat allergy. 
-IgE-ab to wheat (> 0.35kUA/L) and/or a positive SPT to wheat (>3mm). 
-Wheat-free diet. 
 
Exclusion criteria were: 
- Celiac disease or other autoimmune diseases. 
 
 Grass group 3.1.2
Children with a doctor’s diagnosed grass pollen allergy and who had received the diagnostic code J30.1 
and/or H10.1 and/or J45.1 and/or J45.8 (Allergic conjunctivitis and/or allergic pollen rhinitis and/or allergic 
asthma) in ICD-10 were identified in the same paediatric hospital and their corresponding outpatient clinics 
in Stockholm, where the wheat allergic patients were found. 
All children, who fulfilled the inclusion criteria and were willing to participate in the study, were invited to a 
visit at ALB or Sachs’ Children's and Youth Hospital, Stockholm, Sweden. Blood samples were drawn and a 
QoL questionnaire was filled in at the visit. 
Inclusion criteria: 
 -A doctor’s diagnosed grass pollen allergy, IgE-ab to timothy (≥ 0.35kUA/L) and/or positive wheat skin prick 
test (> 3 mm). 
- Clinical symptoms during the grass pollen season.  
Exclusion criteria: 
 -Wheat free diet. 
-Allergy to wheat. 
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 Wheat group 
N=63 
Grass group 
N=72 
Visit 1   
Signing the consent form X X 
Presentation of general information  X X 
Recording the patient’s history of allergy         X X 
Clinical examination  X X 
Taking blood samples  X X 
Filling out QoL forms CHQ-CF87and CHQ-PF28  X 
Visit 2   
Taking blood samples for determination of  CD-sens (N=24) X  
Performance of an OFC wheat (N=57) X  
Filling out QoL forms CHQ-CF87,CHQ-PF28, FAQLQ-CF and FAQLQ-PF X  
Follow-up   
Filling out QoL forms FAQLQ-CF and FAQLQ-PF X  
 
       Table 2. Study design wheat and grass group. 
3.2 STUDY METHODS 
 Oral food challenges  3.2.1
The oral food challenges performed were done by experienced personnel with knowledge about acute 
treatment care at allergic reactions and before the challenge, medical treatment was prepared. All challenges 
were performed at department of Astrid Lindgren´s Children’s Hospital with access to an emergency care unit 
if needed.  
The children had to be healthy at time of the challenge and no challenge was performed if the child had an on-
going infection or an on-going allergic reaction to other food or inhalant allergens. The challenge was also 
postpone if the child had used antihistamine less than 4 days or oral steroids < 2 weeks prior to the challenge. 
A medical history with focus on wheat allergy and medications were performed before the challenges. Heart 
and lung auscultation, blood pressure, inspection of the oral cavity and skin were made before and during the 
challenges.  
The open oral challenge tests to wheat were performed using wheat bread (Pågens, Sweden) with well-
defined wheat content of 0.1/1 g wheat protein/g bread. The bread was given in increasing doses every 30 
minutes in 5 or 7 steps from 0.005 g to 1.7 g of wheat protein. The maximum cumulative dose was 3.38 g of 
wheat protein (one slice of bread). Objective symptoms developing within two hours, which were scored 
according to the criteria of Astier (110)  (Table3), were considered as a positive challenge. The challenges were 
stopped upon appearance of objective symptoms before the last dose was reached. A negative challenge was 
defined as no objective allergic symptoms within two hours after the last dose or no gastrointestinal 
symptoms 24 hours after the challenge.  
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Three children had experienced anaphylactic reactions within six months from the study visit, and three 
additional children refused challenge because of anxiety after experiencing severe reactions within the past 
year. These six children were not challenged for ethical reasons but are in the analyses considered to be 
wheat allergic, but are omitted in the analyses of severity of reaction. 
 
Table 3. Symptom score according to Astier (110). 
 IgE-antibodies  3.2.2
The mix fx5 (Peanut, Cow milk, Egg white, Cod, Soybean, Wheat) and Phadiatop (birch, timothy, mugwort, 
mite, cat, dog, horse, mold) (ThermoFisher former Phadia AB, Uppsala, Sweden) was used for screening for 
common food and inhalant sensitizations at the first visit in the study. Before the challenge was performed 
blood samples were collected and stored in – 20 degrees pending analysis. IgE-ab were analysed for 
ImmunoCAP®( ThermoFisher former Phadia AB, Uppsala, Sweden) to whole wheat, recombinant ω-5 gliadin 
(Tri a 19) and a native gliadin preparation containing α-, β-, γ-, and ω-gliadins (gliadin), all available as 
commercial products. An IgE-ab level >0.35 kUA/L was defined as positive. For Low molecular weight 
glutenin (LMW) and High molecular weight  glutenin (HMW), experimental ImmunoCAP® tests were 
prepared with recombinant LMW-glutenin (Tri a 36) (111) and recombinant HMW-glutenin (Tri a 26) (49, 
85). For HMW-glutenin the cut-off for a positive IgE-ab-level test was defined as 0.35 kUA/L. This was in 
contrast to LMW-glutenin where the test was a research test with a high non-specific background binding 
and hence a  cut-off of 1.5 kUA/L was set based on the mean signal from 20 healthy blood donors + 3 SD.  
IgE-ab were analysed with ImmunoCAP® (ThermoFisher, former Phadia AB, Uppsala, Sweden) for timothy, 
wheat, seven grass- specific components (Phl p 1, Phl p 2, Phl p 4, Phl p 5, Phl p 6, Phl p 7, Phl p 11 and Phl 
p12) and three wheat specific allergen components (Tri a 14, Tri a 19 and gliadin) as well as cross-reacting 
carbohydrate determinants (CCD) and Pru p 3 in children from the grass group. Six experimental tests with 
wheat specific recombinant allergens (two variants of Tri a 20 Tri a 36, Tri a 37, avenin-like protein and β-
amylase) were also included in the panel. The cut-off for positive IgE-ab-levels in these experimental tests 
was set to ≥ 0.35 kUA/l, except for Tri a 36 which had a high non-specific background binding, and 
therefore the cut-off was set to ≥ 1.5 kUA/L based on the mean signal from 20 healthy blood donors + 3 SD.  
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 Basophil allergen threshold sensitivity (CD-sens) 3.2.3
In the cohort described in paper II, blood samples were collected just prior to the challenge start in 13/24 
children. In the remaining 11 cases blood samples were collected between one to ten months after the 
challenge test. The samples were stored at +4°C for a maximum of 24 hours before cell analyses were 
performed. Serum was separated and stored at -20°C pending analysis. 
CD-sens evaluate allergen threshold sensitivity of basophils by using a dose response curve measuring 
percentage of activated basophils at different concentration of an allergen (112). Whole blood was incubated 
with RPMI (negative control) (Gibco Ltd., Paisley, Renfrewshire, U.K), N-formyl-methionyl-leucyl-phenylalanin 
(fMLP) (non-IgE-ab-dependent positive control) (Sigma Chemical Co, St. Louis, MO, USA), anti-FcRI (IgE-ab-
denendet positive control) (Bühlmann Laboratories, Basel, Switzerland) or allergen extracts of wheat (0.01-100 
µg/mL) (IDD Thermo Fischer Scientific, Uppsala, Sweden), recombinant ω-5 gliadin (rTri a 19) (0.001-100n 
ng/mL) (IDD Thermo Fischer Scientific), Hydrolysed Wheat Protein (HWP) (0.01-100 µg/mL) (Meripro 711R, 
Tate&Lyle, Aalst, Belgium) or timothy grass (0.1-100 µg/mL) (IDD Thermo Fischer Scientific, Uppsala, Sweden). 
Following this stimulatory step cells were immune stained with CD203c (Immunotech, Marseille, France) for 
basophil identification and CD63- (Immunotech) for detection of basophil activation. The cells were then 
analyzed in a Navios flow cytometer (Beckman Coulter, Inc., Fullerton, CA, USA). The cut-off value of 5 % of 
CD63-positive basophils was used to define a positive allergen test. 
Basophils from patients which after anti-FcRI stimulation (positive control) responded with <5% CD63-
upregulation, were regarded as non-responders. For individuals with a response between 5-16 % (low-
responders) the results should be interpreted with caution. The cut off 16 % was calculated (mean 76 % -3SD) 
from the positive controls of an in-house reference material of 264 allergic children and adults (90). 
CD-sens was defined as the inverted value for the eliciting allergen concentration giving 50% (EC50) of 
maximum CD63% up-regulation multiplied by 100 [1/EC50×100] and was used to describe the patient’s 
allergen sensitivity (113). A high CD-sens indicates a high basophil allergen threshold sensitivity (92). 
 Inhibition of IgE-ab binding 3.2.4
In paper III sera from patients displaying IgE-ab responses to both timothy and wheat was used to test for 
specific IgE-ab-binding inhibition experiments as previously described (Yman et al, 1975). In order to ensure 
trust worthy results of the analysis the level of IgE-ab to wheat needed to be >1 kUA/l and all but one sera 
meeting this criterion were selected (n=23). Timothy extract (14.4 mg/ml) in two dilutions, 1:1 and 1:1000 
were used as liquid phase inhibitors. Inhibitor and patient serum, in equal volumes, were briefly mixed and 
incubated at room temperature for two hours. Thereafter IgE-ab measurement was done on the solid phase, 
wheat and timothy (control). The level of “no inhibition” was defined by mixing equal volumes of buffer and 
patient serum before a parallel incubation and IgE-ab measurement on the solid phase. Extracts of 
Dermatophagoides pteronyssinus and dog dander were used as control inhibitors, and did not cause inhibition 
of IgE-ab binding to neither timothy nor wheat. 
Simultaneous IgE-ab analysis was also performed using CCD as solid phase, for two sera that had an initial IgE-
ab level >1 kUA/l to CCD. Similarly, for three sera with an initial IgE-ab level to Phl p 12 >1 kUA/l, wheat extract 
(4.8 mg/ml) was used as liquid phase inhibitor in two dilutions, 1:1 and 1:1000, before analysis on the solid 
phase, Phl p 12 and wheat (control).  
Inhibition was defined as the relative reduction of detected IgE-ab response between the two measurements: 
 Inhibition (%) = (IgE-ab binding for sera diluted in buffer – IgE-ab binding for sera diluted in inhibitor) 
                                                            (IgE-ab binding for sera diluted in buffer) x 100 
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 QoL questionnaires 3.2.5
Parents and patients (depending on age) in the wheat group were interviewed with use of four QoL 
questionnaires: the Child Health Questionnaire – Parental-completed form 28 (CHQ-PF28) (114) and the 
Child Health Questionnaire – Child-completed form 87 (CHQ-CF87) and Food Quality of Life Questionnaire – 
Parents Form (FQLQ-PF) and Food Quality of Life Questionnaire – Teenagers Form (FQLQ-TF) (105).   
Parents and patients in the grass group were interviewed with a standardized questionnaire with focus on 
symptoms of grass pollen allergy, asthma, rhinocunjunktivitis, eczema, food allergies, and questions about 
outgrown food allergies and the same questionnaires as the wheat group 
The questionnaires used were in Swedish validated and tested for reliability and translated to Swedish back 
and forth following international guidelines by Norrby et al (115).  
Both CHQ-PF28 and the CHQ-CF87 had items with 4, 5 or 6 response options, divided over 10 multi-items 
(Table 2, Paper IV). The items were summed up (some recoded/recalibrated) and for ease of the 
interpretation the items were transformed into 0 (lowest score) to 100 (highest score), with higher score 
indicating better well-being.  
All questions were based on a retrospective recall of health over the preceding 4 weeks, except for one 
single item that measures change in health over the preceding year. 
3.3 STATISTICAL ANALYSIS 
The statistical analyses were performed using Prism 5, Graph Pad Software, La Jolla, USA (Paper I, II and III) 
and IBM SPSS 22.0, Chicago, ILL, USA (Paper IV). The material from the two Study populations was not 
normally distributed and non-parametric statistical methods were used. No adjustment for multiple testing 
has been performed. Thus, significant results should be regarded as descriptive and explorative. 
 Fisher’s exact test (I, III) 3.3.1
Fisher’s exact test was used for pairwise comparison of categorical data of clinical characteristics in patient 
with wheat allergy challenge positive respectively negative in paper I and in children with grass pollen 
allergy sensitized or not sensitized to wheat in paper III. A p-value <0.05 was considered significant, ns= not 
significant. 
 Mann-Whitney U-test (I-IV) 3.3.2
Mann-Whitney U-test was used for comparison of IgE-ab levels to wheat and different wheat components 
in paper I (wheat, timothy, ω-5 gliadin, gliadin, HMW/LMW- glutenin).  
A p-value of <0.05 was considered significant. Specific IgE-ab levels ≤0.35 kUA/L were set to 0.175 and for 
LMW-glutenin antibody levels ≤ 1.5 kUA/L were set to 0.75 for statistical analyses.  
In paper II the test was used to assess differences in between the children with wheat allergy positive and 
negative challenges. Significance was considered at a p-value of <0.05. 
In paper III the same test was used for comparison of IgE-ab levels to wheat and timothy. A p-value of <0.05 
was considered significant. IgE ab levels under the cut-off were set to 0.05 for statistical analyses. 
 
 
  37 
In Paper IV, differences in demography and characteristics of children diagnosed with grass respectively wheat 
allergy were examined and geometric means and standard deviations (SD) for the different item scores were 
calculated and differences in distribution of parent /children reported geometric mean scores between the 
two groups (wheat and grass allergic patients) were assessed using Mann-Whitney U. To adjust for potential 
confounders, including age (continuous), sex, asthma (yes/no), and pollen season (yes/no), we used a general 
linear model to assess beta coefficients (B) and 95% confidence intervals (CI) to describe the differences in 
CHQ-PF28 and CHQ-CF87 mean scores in wheat allergic subjects compared to grass allergic subjects. 
 ROC curves (I)  3.3.3
ROC curves were calculated for ImmunoCAP specific IgE-ab for wheat and the four wheat components (ω-5 
gliadin, gliadin, HMW/LMW- glutenin), with the food challenge results as reference and reported as the area 
under the curve (AUC). The diagnostic performance, in terms of sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV), for each test was calculated for a cut-off level of 0.35 kUA/L for 
wheat, ω-5 gliadin, gliadin and HMW-gliadin and for a cut-off level of 1.5 kUA/L for LMW-glutenin. The cut-off 
level producing a specificity of at least 90% and 95% (here defined as the positive decision points), and finally 
the cut-off level producing a sensitivity of at least 90% and 95% (here defined as  the negative decision points) 
was calculated for all tests. 
 Spearman rank order correlation (rs) (II, IV) 3.3.4
This test was used in paper II to assess the relation between the wheat challenge, CD-sens, wheat, omega 5 
gliadin, hydrolyzed wheat and IgE-ab measurements. 
Spearman rank order correlation (rs) coefficients were used in paper IV between scores for similar items on the 
parent reported CHQ-PF28 and the child reported CHQ-CF87 for patients with wheat and grass allergy. 
Furthermore it was used to assess the relation between the wheat challenge, CD-sens wheat, omega 5 gliadin, 
hydrolyzed wheat and IgE-ab measurements. 
   Chi-square  3.3.5
Test was used in paper IV for categorical variables, differences in demography and characteristics of children 
diagnosed with grass respectively wheat allergy. 
3.4 ETHICAL APPROVAL  
The studies in the thesis were approved Regional Ethical Review Board at Karolinska Institutet in Stockholm, 
Sweden (Identification number: 2008/562-31/3 and 2011/1833 32). Written informed consent was obtained 
from all study objects and parents before the children were included in the study. 
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4 RESULTS 
4.1 PAPER I 
      Paper I demonstrates that CRD are useful and may improve diagnosis of wheat allergy.      
 Oral food challenges with wheat 4.1.1
We found 102 children who were sensitized to wheat, had a doctor´s diagnosis of wheat allergy and 
eliminated products containing wheat from their diet and seventy six children, aged 1-17 years, fulfilled the 
inclusion criteria (Paper I). 
However, thirteen children were excluded during the study; four children did not fully participate, three 
were negative in IgE-ab to wheat at the inclusion, in three children blood samples could not be obtained , 
two children developed an autoimmune disease and one child did not complete the wheat challenge 
(Paper I, II and IV).  
Sixty-three patients with doctor’s diagnosis of wheat allergy were included in the study.  Blood samples 
were taken before the challenges and a clinical examination was performed (visit 1). 
 An open oral challenge (OFC) with wheat was performed for 57 children after clinical examination (visit 2). 
Six children did not go through an OFC due to history of severe reactions to wheat during last year. 
Thirty-two children (51%) had a positive reaction at the challenge, the wheat allergic group (WA) and 31 
children had a negative challenge test result, non-wheat allergic group (non-WA) (Table 4). 
 There was no significant difference regarding medical history or age (6.5 respectively 4 years) between the 
WA and the non-WA (Table 4). 
 Furthermore there was no significant difference in the prevalence of other allergic diseases, e.g. symptoms 
of grass pollen allergy were found to be equally common in both groups. 
 Noteworthy, the levels of IgE-ab to grass pollen was higher in the WA group, median (range) 5.1 kUA/l 
(<0.35 – 49) than in the non-WA group 0.75 kUA/l (<0.35 – 85). 
The most common allergic reactions during the two hours of observation time at the challenge were 
respiratory symptoms (n=10) followed by rhino-conjunctivitis, angioedema, rash and oral allergy syndrome 
(OAS) (n=8) and other symptoms, urticaria respectively gastro-intestinal symptoms (n=7). 
Out of the 31 non-WA children, only four developed symptoms at the follow-up 72 hours after challenge 
(two gastrointestinal symptoms, two worsening of their eczema and one developed urticaria). None of the 
symptoms were regarded as severe according to the parents. Therefore the advice to continue re-
introduction of wheat into the child’s diet was not changed. 
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Patient characteristics All Final wheat allergy diagnosis p-value 
Non-WA WA 
Total number 63 31 32 ns 
Sex, male/female 41/22 19/12 22/10 ns 
Age, yr; median (range) 5.0 (1–17) 4.0 (1–17) 6.5 (1–17) ns 
Reported allergies; number (%) 
Asthma 41 (65) 17 (55) 24 (75) ns 
Rhino-conjunctivitis 35 (56) 17 (55) 18 (56) ns 
Eczema 40 (63) 18 (58) 22 (69) ns 
Any pollen allergy 43 (68) 22 (71) 21 (66) ns 
Grass pollen allergy 25 (40) 12 (39) 13 (41) ns 
Furry animal allergy 29 (46) 13 (42) 16 (50) ns 
Other food allergy 55 (87) 27 (87) 28 (88) ns 
Egg 49 (78) 24 (77) 25 (78) ns 
Milk 45 (71) 22 (71) 23 (72) ns 
Fish 10 (16) 6 (19) 4 (12) ns 
Peanut/tree nuts 33 (52) 13 (42) 20 (62)  
Table 4. Demographic data and clinical characteristics of all study subjects and in subjects confirmed as wheat 
allergic (WA) or non-wheat allergic (non-WA) based on challenge outcome (n = 57) convincing history of 
anaphylaxis (n = 6). 
 Comparisons of wheat-allergic and non-wheat-allergic subjects 4.1.2
The levels of IgE-ab s to each of the four studied components (ω-5 gliadin, HMW-glutenin, LMW-glutenin and 
gliadin)  and to wheat was significantly higher in WA children compared to non-WA (p < 0.001)  (Fig 10). All six 
children that were considered to be wheat allergic but that were not challenged had detectable IgE-ab to all 
four wheat components.               
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Fig 10. IgE-ab levels to wheat and wheat components in 32 children with WA (●) and 31 non-WA (○) 
children. Statistical significance was calculated based on the presence or absence of IgE-ab above the set 
thresholds for each test (***refers to a level of significance <0.001). 
Receiver operating characteristic (ROC) curves was calculated for all components and showed that IgE-ab to 
HMW-glutenin had the largest area under the curve (AUC) 0.88, while AUCs varied between 0.78 and 0.82 
for the other wheat components tested (Table 5). At the respective assay cut off points for each test, ω-5 
gliadin had a specificity of 84 % and a sensitivity of 62%, while gliadin, HMW-glutenin, and LMW-glutenin 
had sensitivities of 81–94 % and specificities between 29 and 52 % (Table 5). The positive decision points 
based on at least 95 % clinical specificity in the diagnosis of wheat allergy were 70 kUA/l for wheat, 1.3 
kUA/l for ω-5 gliadin, 6.0 kUA/l for gliadin, 1.4 kUA/l for HMW-glutenin, and 4.0 kUA/l for LMW-glutenin 
(Table 5). Negative decision points, defined as a sensitivity of at least 95%, were only possible to calculate 
for wheat (8 kUA/l) and HMW-glutenin (0.35 kUA/l) (Table 5). 
Diagnostic performance Wheat allergens 
Wheat (f4) ω-5 gliadin Gliadin HMW-glutenin LMW-glutenin 
ROC/AUC 0.91 0.78 0.83 0.88 0.82 
Assay cut-off point 
Specific IgE-ab level (kUA/l) 0.35 0.35 0.35 0.35 1.5 
Sensitivity, Specificity (%) 100, 6 62, 84 94, 29 97, 42 81, 52 
PPV, NPV (%) 52, 100 80, 68 58, 82 63, 93 63, 73 
Positive decision point (95% spec) 
Specific IgE-ab level (kUA/l) 70 1.3 6.0 1.4 4.0 
Sensitivity, Specificity (%) 62, 97 44, 97 69, 97 66, 97 56, 97 
PPV, NPV (%) 95, 71 93, 62 96, 75 95, 73 95. 68 
Negative decision point (95% sens) 
Specific IgE-ab level (kUA/l) 8.0 None None 0.35 None 
Sensitivity, Specificity (%) 97, 58     97, 42   
PPV, NPV (%) 70, 95     63, 93   
        Table 5. ROC/AUC calculations for wheat components.   
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 Relation between symptom score and IgE-ab levels to wheat components 4.1.3
For the children that reacted positively at challenge, the severity of reactions was graded according to 
Astier (Table 3) and resulted in a median score of 2.5 on a five-point graded scale. Thirteen children were 
graded as score 1, four score 2, and nine score 4. No child was classified as having scores 3 or 5. A higher 
score indicates a more severe reaction. 
The challenge positive children (n = 26) were divided into two severity groups (mild = severity score 1 and 
2; severe = score 4), and the IgE-ab levels to wheat components were compared to those of non-WA 
children (Fig 11). Both severity groups had significantly higher levels of IgE-ab to all four components as 
compared to non-WA (p between >0.05 and >0.001), apart from gliadin where there was no difference 
between mild reacting children and non-WA. Children with severe symptoms compared to those with mild 
symptoms had significantly higher IgE-ab levels to gliadin, HMW-glutenin and LMW-glutenin (p > 0.05) but 
not to ω-5 gliadin.  
 
 
Fig 11. IgE-ab levels to four gluten-derived wheat components in 31 non-WA and 26 children positive in 
wheat challenge divided into groups with mild and severe symptoms, respectively. Results are presented 
as the 25th to 75th percentile of the values with the median and min to max indicated. Statistical 
significant differences between the groups are indicated (*refers to a level of significance <0.05, **<0.01 
and ***<0.001). 
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4.2 PAPER II 
Paper II showed that combining CD-sens and IgE-ab to wheat or wheat components may be useful in the 
diagnosis and follow-up of wheat-allergic children. 
 Challenge Outcome 4.2.1
Of the 24 patients included in the study, 12 (50 %) had a positive reaction at the oral wheat challenge (table 6). 
The median age of those with a positive challenge test was 7 (2-15) years and for children with a negative 
challenge it was 4 (2-13) years.  
The outcome of the challenge was only reported as positive or negative (table 6) even though a scoring of all 
symptoms was done. Of the 12 patients with a positive challenge, 8 had mild-to-moderate symptoms (grade 1-
3) and 4 patients experienced severe symptoms (grade 4). 
The challenge positive children had significantly higher concentrations of IgE-ab to wheat (p < 0.01), to ω-5 
gliadin (p < 0.005) and to HWP (p < 0.005) compared to children with a negative outcome at the challenge. 
There was no significant difference between IgE-ab levels to timothy in the challenge-positive as compared to 
the challenge-negative group. 
 All patients in paper II (n = 24) were tested for CD-sens to wheat, ω-5 gliadin and timothy. All 21 patients had 
a positive CD-sens to wheat and there was a tendency (p = 0.08) for the wheat CD-sens value to discriminate 
between children positive or negative in wheat challenge. Children with a positive challenge had higher levels 
of CD-sens. 
 Six of 11 children with a positive challenge also had a positive CD-sens to ω-5 gliadin.CD-sens for HWP was 
performed only in 20/24 patients due to scarcity of material and was possible to evaluate in 17 patients. 
Eleven of those 17 patients had a positive CD-sens reaction to HWP, and 7 of these 11 were positive in wheat 
challenge. 
 
 
 
 
 
 
 
 
 
 
 
 
  43 
 
 
IgE-ab (kUA/L) CD-sens 
Patient Wheat 
challenge 
Wheat ω5-
gliadin 
HWP Timothy Wheat ω5-
gliadin* 
HWP Timothy 
1 + 37 0.18 20.2 0.59 1659 + n.t. 150 
2 + 11 0 6.0 2.0 303 - n.t. 6.9 
3 + 3.7 0.27 0.47 6.4 5.0 + 0 71.7 
4 + 2500 14 160.4 20 1305 + 191 3.5 
5 + 255 4.3 108.4 6.6 9896 + 814 169 
6 + 40 0.62 13.6 49 1678 - 49.6 583 
7 + 35 0.34 14.6 0.43 1046 - 11.8 1.87 
8 + 22 0.12 8.2 0.36 515 + 75 + 
9 + 93 0.13 26.6 0 n.r. n.r. n.r. n.r. 
10 + 940 4.1 47.3 0.17 + - 0 0 
11 + 72 0.29 28.9 1.0 5326 + 13 7.56 
12 + 57 0 10.8 13 177 - 23.7 4.26 
13 - 14 0 2.8 0.97 1145 - 32.4 8.2 
14 - 5.3 0.11 1.3 0 319 - 0 0 
15 - 7.8 0 0 5.9 12.7 - 0 345 
16 - 6.7 0 2.1 0 621 - 8.32 1.98 
17 - 1.3 0 0.2 0.96 n.r. n.r. n.r. n.r. 
18 - 69 0.17 3.8 4.5 55.5 - 3.05 3.18 
19 - 31.8 0.05 4.0 0 62.1 + 0 0 
20 - 6.6 0 5.9 1.6 17.3 - 0 1.94 
21 - 74 0 37.3 3.0 1427 - 23.9 3.1 
22 - 18 0 3.0 0.12 514 - n.t. 0 
23 - 2.9 0.21 0.41 0.73 51.7 - n.t. 0 
24 - 0.6 0 0.15 0 l.r. l.r. l.r. l.r. 
        n.t. = not tested; n.r. = non responder; l.r = low responder; + = positive; - = negative 
         Table 6. Serological and cellular results. 
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 Challenge outcome in relation to combination of IgE-ab and CD-sens 4.2.2
There was a significant correlation between the levels of IgE-ab and the CD-sens values to wheat (r = 0.64, p < 
0.003; fig. 12 a). If a wheat CD-sens value >150 was combined with a wheat IgE-ab concentration >20 kUA/l, or 
IgE-ab to ω-5 gliadin >0.1 kUA/l, 83% of the wheat challenge outcomes were predicted. If the non- and low 
responders were excluded, the agreement was 91%.  
There was also a significant correlation between the level of IgE-ab to HWP and the CD-sens to HWP (r = 0.59, 
p < 0.05; fig. 12 b). All challenge-positive children, except 2 non-responders, had a CD-sens value to HWP >10 
and an IgE-ab level to HWP >8 kUA/l. Five children had IgE-ab to HWP but were negative in CD-sens to HWP. Of 
these 5 children, 3 were also negative in the wheat challenge (fig 12c). 
     
 Fig 12. IgE-ab  in relation to basophil allergen threshold sensitivity, CD-sens, for wheat (a) and HWP (b). 
(c) CD-sens to HWP in relation to CD-sens to wheat. ● = Positive challenge; ○= negative challenge.                        
  45 
4.3 PAPER III 
Paper III demonstrates that the majority of grass allergic individuals had IgE-ab to wheat, however at low 
concentrations. This is interpreted as cross reactivity between grass pollen and wheat and could in one third of 
the patients be explained by sensitisation to profilins and CCD.  
 Sensitization to grass, wheat and related components 4.3.1
Seventy-four children were included in the study but two children were excluded when they neither had 
clinical symptoms nor IgE-ab for grass (Paper III and IV).  Forty-seven (65 %) were boys and the median age 
was 12 (5-17) years. Sensitization to wheat was confirmed in 43 (60 %) of the children (Fig 13). Another four 
children had a history of wheat allergy but they had developed tolerance. Comparing the wheat sensitized 
children (n=43) to the non-wheat sensitized, timothy allergic children, there was no differences regarding 
reported asthma, rhino-conjunctivitis, eczema and food allergy. The medical records for the patients showed 
that egg, milk, soy, fish and nuts/peanuts were the major allergens causing both past and current allergies.        
                                
 
Fig 13. IgE reactivity to timothy and wheat in 72 children with grasspollen allery.All children displayed IgE-
ab-ab to timothy (median level 20 kUA/l) and out of these 44 children were sensitized to wheat (median level 
1,2 kUA/l) 
The median level of IgE-ab response to wheat in sera from the 72 children was 1.2 kUA/l with a maximum level 
of 12.2 kUA/l . The IgE-ab response to timothy was significantly higher than that to wheat (p<0.001). 
Furthermore the IgE-ab responses to seven different wheat specific allergen components were also measured. 
The most frequent IgE-ab response was obtained to the wheat LTP component Tri a 14 (15 %) followed by 
Gliadin, Tri a 36, and avenin-like protein (all 4 %), and Tri a 19, Tri a 20long, Tri a 37 and β-amylase (all 3 %), and 
Tri a 20short (1 %). The level of IgE-ab responses to wheat components were generally low, <1.5 kUA/l. 
Twenty-three sera with an IgE-ab response >1 kUA/l to wheat were inhibited with timothy extract and the 
degree of inhibition varied between 11-94%, with a median inhibition degree of 66 % with timothy extract 
diluted 1:1 
 46 
 Inhibition of specific IgE responses to CCD and profilin 4.3.2
Of the children included in the study five out of 72 sera displayed IgE reactivity to CCD and the response 
ranged between 0.4-7.8 kUA/l. All sera also displayed a simultaneous IgE-ab response to wheat. Inhibition 
of two sera, both with an IgE-ab to CCD and wheat >1 kUA/l, with timothy extract reduced the binding to 
CCD and wheat by 94-98% and 86-92%, respectively. Sera from 14 children displayed IgE-ab to timothy, 
profilin and Phl p 12 and out of these 12 children had a simultaneous reactivity to wheat. Further, two sera 
also displayed simultaneous reactivity to CCD and wheat. Inhibition of five sera, with an IgE-ab response to 
both Phl p 12 and wheat >1 kUA/l, with wheat extract reduced the binding to Phl p 12 and timothy by 19-
90% and 7-20%, respectively (Table 7). 
        
Simultaneous IgE reactivity n(%) 
Timothy 
Wheat 
Timothy 
Wheat 
Profilin 
Timothy 
Wheat 
CCD 
Timothy 
Wheat 
CCD 
Profilin 
43(60%) 12(17%) 5(7%) 2(3%) 
Table 7. Number of children displaying simultaneous IgE reactivity to timothy, wheat, CCD and profilin. 
 
4.4 PAPER IV 
Paper IV demonstrates that wheat allergy impairs health-related-quality-of-life more than grass allergy in 
childhood. 
 Parental CHQ-PF28 questionnaire 4.4.1
Fifty-five parents of the 63 wheat allergic children filled out the CHQ-PF28 questionnaire (Table 8). The 
domain with the lowest score was Parental impact-Time (61.4) whilst the domain Role/Social limitations-
Emotional- Behavioural received the highest score (87.4). 
Of the grass allergic patients 68 out of 72 answered the questionnaire (Table 8). For this group the Change 
in the Health domain received the lowest score (67.3) and Role/social limitations-Emotional- behavioural 
received the highest score (94.1). There was a significant difference between the parent’s perception and 
their wheat allergic children for five items compared to parent’s perception and their grass allergic children. 
These items were general behaviour (p<0.0001), general health perceptions (p=0.001), parental impact of 
emotions (p=0.001), and time (p<0.0001), as well as family activities (p=0.001).  Interestingly, the opposite 
was true for the item Change in Health. The parents of the grass allergic group scored this item significantly 
lower (p=0.020) compared to the wheat group’s parents. 
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Items Wheat allergic  
(n=55) 
geometric mean 
SD Grass allergic 
(n=68) 
geometric mean 
SD P-value* 
Physical functioning 86.5 18.3 90.1 11.0 0.350 
Role/social limitations-
Emotional- 
behavioural 
87.4 20.3 94.1 13.1 0.323 
Role functioning: 
Physical       
85.9 19.4 91.8 15.3 0.119 
Bodily pain                             81.0 18.9 77.4 22.7 0.956 
General behaviour                        61.8 11.6 75.7 15.1 <0.0001 
Mental health                              77.5 14.2 78.5 15.2 0.520 
Self esteem  82.2 13.7 84.3 12.8 0.478 
General health 
perceptions 
81.7 18.8 91.8 18.6 0.001 
Change in health 74.3 18.0 67.3 18.5 0.020 
Parental impact- 
Emotional  
70.2 23,0 86.3 14.3 0.001 
Parental impact-  
Time  
61.4 18.3 73.9 10.4 <0.0001 
Family activities  72.7 22.9 88.8 14.3 0.001 
Family cohesion  66.1 20.7 71.7 20.6 0.195 
        * Differences in distributions of scores across groups tested using Mann-Whitney U-test.  
 
Table 8. Parent-reported geometric mean scores (standard deviation, SD) for the CHQ-PF28 among children 
with wheat allergy and grass allergy respectively. Score range from lowest score 0 and highest score 100.  
 Children CHQ-CF87 questionnaire 4.4.2
Of the wheat allergic children 27 out of 63 were able to read and fill out the CHQ-CF97 questionnaire (Table 9). 
Mental Health received the lowest score (68.5) and the item that with the highest score (99.7) was Role 
functioning: Behaviour. 
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Amongst the grass allergic, 51 out of 72 children filled out the questionnaire (Table 9). A similar pattern was 
seen for the grass allergic group. Again it was Mental Health (66.0) that received the lowest score and the 
item that received the highest score (95.5) was Role functioning: Behaviour. 
The grass allergic children reported significantly lower scores for four items compared to the wheat allergic 
children. These are Physical functioning (p=0.008), Role functioning; Emotions (p=0.005), Role functioning:  
Behaviour (p=0.029) and Self-esteem - overall subjective emotional evaluation (p=0.035). The wheat 
allergic children did not score lower than the grass allergic children in any of the recorded items. 
Items Wheat allergic  
(n=27) 
 geometric mean 
SD Grass allergic  
(n=51) 
geometric mean 
SD P-value* 
Physical functioning                 96.1 7.9 93.0 8.2 0.008 
Role functioning: 
Emotional   
99.0 2.7 90.4 13.8 0.005 
Role functioning: 
Behaviour       
99.7 1.6 95.5 8.7 0.029 
Role functioning: 
Physical         
96.6 7.4 91.8 12.5 0.167 
Bodily pain                              83.9 13.5 77.9 18.1 0.250 
General behaviour                        81.9 13.7 82.5 9.8 0.468 
Mental health                            68.5 5.4 66.0 6.4 0.179 
Self esteem  88.1 10.6 82.1 11.4 0.035 
General health 
perceptions 
74.2 12.5 73.7 13.7 0.832 
Change in health  64.2 17.8 67.8 21.1 0.324 
Family activities  87.2 10.8 86.3 12.4 0.941 
Family cohesion  69.8 20.1 66.5 22.2 0.899 
 
           * Differences in distributions of scores across groups tested using Mann-Whitney U-test.  
Table 9. Child-reported geometric mean scores (standard deviation, SD) for the CHQ-CF87 among children 
with wheat allergy and grass allergy. Score range from lowest score 0 and highest score 100. 
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5 DISCUSSION 
 
This thesis focus on wheat allergy and the aim was to evaluate the characteristics of patients IgE sensitized to 
wheat, both clinically and immunologically through wheat challenges, component resolved diagnostics (CRD), 
basophil stimulation in vitro (CD-sens)  and quality of life (QoL).  
5.1 ORAL WHEAT CHALLENGES 
The only available procedure to confirm whether a patient is truly allergic to food or not, is to perform an oral 
food challenge test.  
The preferred method is the double-blind placebo-controlled food challenge (DBPCFC), both in the clinic as 
well as in research. There are a number of guidelines for how to perform a DBPCFC (94, 97). The advantage 
with DBPCFC is that it reduces the possible anxiety related reactions compared to an open oral food challenge 
test (OFC). The disadvantage is that DBPCFC is time-consuming and more complicated to perform. The reason 
for performing OFC in our study was to optimize the recruitment and compliance of our study patients. Some 
parents were not willing to participate in two challenges and we were eager to have as representative sample 
of wheat allergic individuals as possible.  We can only speculate if we would have received different results if 
we would have used DBPCFC instead of OFC. Four children reacted with mild late onset symptoms, after the 
challenge, when they had returned home. These symptoms would have been easier to interpret if DBPCFC had 
been used from a clinical point of view. However, this did not change the study results as we only included 
immediate type symptoms during the challenge and up to two hours after challenge. 
Half of the children with a doctor´s diagnose of wheat allergy in our study did not react when challenged to 
wheat indicating an over-diagnosis of wheat allergy. However, some of the children might have been wheat 
allergic but have grown out of the disease but they have not been evaluated. This emphasises the need to 
follow up children with wheat allergy regularly and to perform challenges in daily practise. This is important 
especially in patients on a wheat free diet where the clinical history is not aligned with serological tests. 
Performing a wheat challenge is even more important when CRD is not available. Our data has recently been 
confirmed by Winberg et al in their population based cohort Study in northern Sweden (116). They show there 
was a high discrepancy in the prevalence of allergy to cow´s milk, hen´s egg, cod and/or wheat as estimated by 
reported data versus determination by clinical evaluation or DBPCFC. 
The reason for not reacting to wheat in our study is most probably due to tolerance development or to over-
diagnosis caused by a cross-reaction between wheat and allergens of other origin such as cross-reacting 
carbohydrate determinants and/or profilins from pollen.  It is therefore important to continuously evaluate a 
child with a wheat allergy diagnosis serologically. If the IgE-ab to wheat and its relevant components indicate 
tolerance development, then a challenge should be performed as soon as possible. 
5.2 USEFULNESS OF CRD AND CD-SENS IN WHEAT ALLERGIC PATIENTS  
 CRD to wheat components 5.2.1
We investigated the diagnostic properties of wheat component IgE-ab compared to OFC to wheat. The levels 
of IgE-ab to wheat gluten-derived components gliadin, ω-5 gliadin, HMW-glutenin and LMW-glutenin 
correlated well with the OFC outcome and severity. Children with a confirmed WA had significantly higher IgE-
ab levels to gluten-derived wheat components compared to the challenge negative group non-WA. 
Furthermore the severity of the reactions at the challenge correlated with the IgE-ab levels to these wheat  
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components. The more severe reactions the higher the levels of IgE-ab to the gluten-derived components. 
The IgE-ab levels were also very high in children with a convincing recent history of wheat allergy. 
In our study the wheat extract test had high sensitivity which, at least in part could be explained by the 
inclusion criteria of positive wheat IgE tests. However the specificity was very low, illustrating the need for 
more specific diagnostic tools, as suggested by others (5, 9).  
The ω-5 gliadin was the component showing the highest specificity and was best in discriminating between 
children with WA from non-WA children. This finding is supported by previous reports in the literature 
where gliadins have been shown to be useful in SPT in the diagnosis of WA children (39). The sensitivity of 
IgE-ab to ω-5 gliadin in our study was rather low (62%), and one-third of the WA children were not 
sensitized to ω-5 gliadin. However, the eleven children without ω-5 gliadin IgE-ab were all sensitized to one 
or more of the other three gluten-specific allergen components (HMW/LMW-glutenin and gliadin). Others 
have reported that wheat-allergic patients more frequently have IgE-ab to LMW-glutenin than to ω-5 
gliadin (84). Even so not all wheat-allergic patients could be identified by combining IgE-ab against LMW-
glutenin and ω-5 gliadin in that study. Simonato et al (77) found a relation between the presence of IgE-ab 
to LMW-glutenin and gastrointestinal symptoms after wheat ingestion. The results from our study indicate 
that also in WA with immediate reactions, IgE-ab to a combination of gluten-derived component improves 
the prediction of clinical symptoms.  
Hydrolyzed wheat protein (HWP) is often used in food or cosmetics and it can cause the same reactions as 
gluten when ingested. In many cases, HWP is a hidden allergen due to its emulsifying function and might 
easily not be detected as a wheat allergen. Of the 24 children in paper ll, all were positive to IgE-ab to 
wheat, 96 % also had IgE-ab to HWP. This conforms with the theory suggested by Leduc et al (117) that 
human subjects appear to be easily sensitized to HWP. One possible explanation is that since HWP is not a 
natural protein, human subjects have not had sufficient time to develop tolerance compared to regular 
staple foods. We suggest that the patients with a strict wheat-free diet also should take precautions to 
avoid HWP.  
 CD-sens to wheat and some wheat components 5.2.2
CD-sens were analysed in a subpopulation of 24 children and the purpose was to show whether basophils 
stimulated with wheat, ω-5 gliadin and HWP or a combination of CD-sens and IgE-ab to wheat and/or ω-5 
gliadin could enhance the prediction of the wheat challenge outcome (Paper II).  
Neither CD-sens or IgE-ab to ω-5 gliadin alone provided a satisfactory prediction of the challenge outcome 
hence we combined the different markers and a combination of CD-sens to wheat >150 together with IgE-
ab to wheat >20 kUA/l or IgE-ab to ω-5 gliadin >0.1 kUA/l gave a prediction of 83% of the challenge 
outcome. Compared with Ebisawa et al (81) this represents a diagnostic improvement for recombinant ω-5 
gliadin based on challenge in Japanese children.  Based on our data, we can speculate that the basophils 
only in the severe wheat-allergic patients react to HWP and that this hypersensitivity is not a separate 
entity as suggested by Chinuki et al (118).   
Tokuda et al (119) reported that basophil response to ω-5 gliadin predicted wheat allergy in children, a 
finding we cannot confirm based on our material.  In our study we used recombinant ω-5 gliadin whilst 
Tokuda et al used both purified native ω-5 gliadin and recombinant ω-5 gliadin. They found the native form 
of ω-5 gliadin to discriminate better than the recombinant form which could explain the difference 
between the two studies.  
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The children who did not react to the wheat challenge non-WA, were younger, and had lower, but detectable, 
CD-sens values and lower concentrations of IgE-ab to wheat compared to WA. Thus we speculated that IgE-ab-
sensitized basophils precede target organ sensitivity and thus might indicate later development of clinical 
symptoms of food allergy as well as future airway allergy. This was in contradiction by the findings from paper 
lll where half or our timothy allergic children were IgE sensitised to wheat but tolerated wheat. Four of them 
reported a previous wheat allergy. 
It is well known that sensitisation to wheat is far more common than true wheat allergy (5, 17) (60). To 
diagnose wheat allergy is often complicated by a concurrent pollen allergy leading to cross reactions timothy 
and to false-positive wheat extract test results. It is often unclear whether the wheat sensitization reflects a 
specific IgE-ab-response to wheat or a potential cross-reactivity with pollen allergens.  Thus, there is a need for 
more specific wheat allergy biomarkers.  It is also unclear how common sensitization to wheat is among 
timothy pollen allergic individuals. In paper l we compared children with wheat allergy to those who were not 
wheat allergic and found that the number of children with symptoms of timothy pollen allergy was equal. 
Interestingly, we found significantly higher levels of IgE-ab to timothy pollen in the WA group compared to 
non-WA, even though there was no difference in the sensitization rate of timothy in the two wheat groups. 
These children also had higher IgE-ab levels to wheat extract; indicating that sensitization to timothy pollen 
influences the apparent IgE-ab level to wheat. A previous study has shown that 65% of the patients with 
timothy pollen allergy had false-positive IgE-ab test results to wheat extracts (103). In our paper ll we utilised 
CD-sens and we saw similar results since most of the children with IgE-ab to wheat also had IgE-ab to timothy 
and that they had a positive CD-sens to the same allergens. To our knowledge, this has not been shown before 
and is in contrast to findings of Jones et al (8) that showed little in vitro cross-reactivity to timothy among WA 
patients. One of our most interesting findings is that 65% of the children that had IgE-ab and a positive CD-
sens to timothy had no symptoms to timothy pollen. There is thus a need for markers that truly can 
differentiate between primary wheat sensitization and cross-reactive sensitization. 
5.3 CROSS-REACTION BETWEEN CHILDREN IGE SENSITIZED TO TIMOTHY AND WHEAT 
 CRD to wheat and timothy 5.3.1
We investigated children IgE sensitised and allergic to timothy of whom all tolerated wheat, for IgE-ab to 
wheat and timothy components and compared them to the children with a doctor´s diagnose of wheat allergy 
(Paper III).  
Almost two thirds of the timothy allergic children had IgE-ab to wheat supporting serological data from other 
studies (104, 120). Sensitization to both wheat and timothy may be explained by a serological relationship 
between the two allergens, i.e. cross-reactivity. Simultaneous sensitization could also be due to co-
sensitization to the two allergens or a combination of co-sensitization and cross-reactivity. 
When studying the frequencies and levels of IgE-ab to wheat specific components, among the timothy allergic 
children, low levels were found in most children. Almost all responders were found in the group of children 
with dual sensitization to timothy pollen and the whole wheat extract. The highest frequency of IgE-ab 
responses was to wheat LTP (Tri a 14), and it was significantly higher in the wheat sensitized children. Tri a 14 
is a cross-reactive allergen found in many foods, trees and weeds but not in timothy and has also been shown 
to be associated with symptoms when eating wheat (111, 121-123). Possible explanations for the IgE-ab 
responses to Tri a 14 found in these children currently eating wheat could be the presence of remaining IgE-ab 
from an earlier sensitization connected with wheat allergy, cross-reactivity from other cereals or a wheat 
sensitization without current symptoms. Interestingly, only four of the timothy pollen allergic children had 
experienced wheat allergy in the past. A wheat specific allergen associated with symptoms to wheat is 
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 ω-5 gliadin (Tri a 19) (4, 50, 124). Among the timothy allergic children only two had IgE-ab to Tri a 19. One 
of them had a rather high level (4.1kUA/l) but both children tolerated wheat.  
 Inhibition test 5.3.2
In paper lll we used timothy pollen extract to inhibit the IgE-ab response to wheat.  We could demonstrate 
complete inhibition in only a minority of patients, whilst inhibition of the remaining sera varied a lot, 
indicating partial cross-reactivity between the two allergens. Profilin and CCD are two known cross-reactive 
allergens present in both wheat and timothy pollen and cross-reactive responses due to these allergens 
have been suggested but not proven (9, 125, 126). In our study about a third of the children displaying 
sensitization to both wheat and timothy had IgE-ab to profilin and/or CCD. This means that the dual 
sensitization pattern only partially can be explained by cross-reactivity. Cross-reactivity depending on 
sensitization to profilin and CCD was also to our knowledge for the first time demonstrated in this study. 
This finding that we could only partial explain the cross-reactivity was somewhat surprising. It is therefore 
necessary to continue to search for alternative explanation of these unknown cross-reacting allergens.  
We conclude regarding cross-reactivity between timothy and wheat that most children sensitized to foods 
in our study are also co-sensitized to at least one aeroallergen. Another study found similar serological 
pattern in a large group of children referred from primary care for allergy testing (127). They found that 
75% of the children sensitized to wheat were also sensitized to timothy pollen.  Of the children sensitized 
to timothy pollen, 19% were sensitized to wheat.  Our corresponding figures were 73% and 60% 
respectively. The higher numbers reported by us could be explained by that all our subjects had a doctor’s 
diagnosis of wheat or timothy allergy respectively. This might be interpreted that the more pronounced 
and diagnosed allergic disease you have the higher likelihood of having a co-sensitization for timothy pollen 
and wheat. It is well known that birch pollen allergy is often associated with food allergy, mainly to nuts, 
fruit and vegetables due to cross-reactivity with pathogenesis related allergen-10 (PR-10). Almost two 
thirds of patients in our study had a simultaneous allergy to birch pollen and 87 % were also sensitized to 
birch.  
Current food allergy was reported by 60 % and out of these nearly all reported allergy to peanut and/or 
hazelnut.  The most surprising finding was that more than half of the subjects, apart from the birch pollen 
related food allergies, also claimed that they were allergic to staple foods such as milk, egg, soy and fish.  
Furthermore, the wheat sensitized individuals reported significantly more often both current and past food 
allergy to staple foods than those who were non-sensitized to wheat. One way to interpret these results is 
that wheat sensitization may be a marker of current or past IgE-mediated food allergy in pollinosis patients. 
Our findings that presence of wheat sensitization in timothy pollen allergic patients should not just be 
regarded as cross-reactions due to pan-allergens 
 
5.4  HRQL IN CHILDREN WITH WHEAT RESPECTIVE TIMOTHY ALLERGY 
We have compared health related quality of life (HRQL) in families with children allergic wheat to families 
with timothy allergic children. The main difference was that the parents with a wheat allergic child scored 
significantly lower than parents with a timothy allergic child in several of the domains investigated. These 
items were general behaviour, general health perceptions, parental impact of emotions, and time, as well 
as, family activities. This could be interpreted as food allergy causes more stress to the family due to the  
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increased risk for more severe reactions, including anaphylaxis. Also the activities of daily life are potentially 
impacted by issues such as label reading of commercial food products, concerns for cross-contamination, 
careful cooking at home and worries about school canteens. The results are supported by the findings by 
Cummings et al. that having a child with nut allergies had a significant impact on psychological distress and 
HRQL for the mothers (128) (3). 
Our findings for the wheat allergic group are comparable with the findings for an American group of food 
allergic children (27). Both our Swedish group and the American group had similar scores for General health, 
Parental impact-Emotional and Family activities. However, our group had lower scores for Parental impact-
Time compared to the American group (61 vs. 85), eg. Swedish families spend more time due to food allergy 
compared to American families. A possible explanation could be that the Swedish children are younger, 
median age; 5 years vs. 11 years in the American group, and therefore need more attention. Another 
explanation is that the most common food allergy in the American group was peanut allergy. Both peanut and 
wheat allergy demand strict avoidance but wheat allergy probably in addition has a larger impact on home 
cooking as wheat is a staple food. 
Another interesting finding is the difference of the General health perception as the American families report 
lower score (60 vs. 82) compared to the Swedish parents. The description of a low score is that the child 
believes it´s health is poor and is likely to get worse. One reason could be that the American sample may be 
biased toward a more severe allergic phenotype as the subjects were recruited by the Food Allergy and 
Anaphylaxis Network. 
To the best of our knowledge, Child Health Questionnaire has not been used in children with allergic rhinitis 
due to timothy pollen allergy although it is commonly used in asthma studies.   One study found that especially 
in children with persistent wheezing the HRQL was affected, particularly in general health perceptions and 
physical domains (129). Norrby and co-workers have also studied HRQL in Swedish children diagnosed with 
asthma (115). When comparing the results with our findings, parents in our timothy group report higher score 
than parents to asthmatic children in Self Esteem and General Health Perception. This is surprising as almost 
80% of the timothy allergic children in our study reported asthma as a symptom. This might be explained by a 
difference in severity of asthma symptoms, i.e. that our group had less severe symptoms.  
Generally there was a better correlation between the timothy allergic children’s and parents’ perception of 
HRQL than between wheat allergic children´s and their parents’, in our study. Higher correlations between 
parents and children’s responses specifically on Physical functioning were found for the timothy group . This 
was also seen in the asthmatic group described by Norrby et al. Low correlation between children and parents 
for our timothy group and for the asthma group in Norrby’s study were found for the General behaviour, Role 
functioning-Emotional and Role functioning-Behaviour domains. This might indicate that it is more difficult for 
parents to evaluate their children’s psychological health than the physical health. Children and parents do not 
necessarily share similar views about the impact of illness. It is important to directly involve children and 
teenagers in the management and care, when we meet them as patients at our allergy clinics. 
5.5 STRENGTHS AND WEAKNESSES OF THE PRESENT INVESTIGATIONS   
 Study design 5.5.1
The results should be interpreted with caution since they are based on a limited number of patients but we 
believe that it raises interesting questions that need long-term follow-up. 
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A strength of our study is that all patients in the wheat group had a doctors diagnose of wheat allergy 
hence they all were on a diet without wheat. All patients were also sensitized to wheat. An oral food 
challenge was performed in all patients except six who had a convincing history of anaphylactic reactions 
during the last year. A weakness is that these groups of patients are selected and not population based. 
In the timothy group all patients had a doctors diagnose of timothy allergy, they were sensitized to timothy 
and they all tolerated wheat. Again these patients represent a selected group and are not population 
based. One limitation of this study is that a majority of the subjects were identified and recruited from 
pediatric university clinics and less so from pediatric primary care clinics. A consequence of this might be 
that our subjects are more likely to have more severe timothy pollen allergy and associated co-morbidities. 
 OFC 5.5.2
In research the DBPCFC is regarded as a golden standard for diagnosis of food/wheat allergy. However the 
procedure is laborious and requires skilled personnel and comes with a risk for the patient. A limitation of 
this study (paper I, II) is that all the wheat challenges were performed as open food challenges but since the 
Astier scoring method only takes objective symptoms into consideration, we regard this challenge 
procedure only to be a minor drawback in the study design. Strength is that all challenges were made in the 
same unit with same experienced personnel and with a trained allergologist present. Furthermore, when 
performing the oral challenge test, we have used ordinary wheat products which have been heated when 
produced. Hence, we cannot exclude that the wheat proteins have undergone changes in this process.  
 CD-sens 5.5.3
The strength is that the wheat challenges and CD-sens analyses have been performed and evaluated by the 
same experienced personnel. 
Non and low-responders in CD-sens have been described previously (113, 130, 131) and is a weakness of 
the method. In our study one patient with a positive challenge test was a non-responder in CD-sens and in 
the group of patients negative in the challenge test one was a non-responder and one a low-responder. 
The consequence of this is that an oral challenge has to be performed on individuals who are low- or non-
responders in the CD-sens test.  
We used the recombinant form of ω-5 gliadin, for stimulation of basophils, but had some solubility 
problems. The basophils require a physiological pH in contrast to ω-5 gliadin, which should be dissolved in 
1% acetic acid. Since we may have encountered solubility problems, we could not guarantee the exact 
amount of allergen in the solutions used and we therefore chose to describe CD-sens to ω-5 gliadin only as 
positive or negative.  
 Blood samples and component analysis 5.5.4
The time between challenge and blood sampling should not have exceeded 6 months due to the increased 
possibility that the child's target organ sensitivity might have changed, i.e. developed tolerance. Three 
children exceeded this time interval, but they were not excluded because they all had a negative challenge, 
which had no consequence for the results. The IgE-ab concentration for wheat might not have been 
affected because most children had been avoiding wheat for a long time. IgE-ab concentration for timothy 
might have been affected due to the pollen seasonality. 
  55 
 HRQL 5.5.5
The major strength of this study is the validated questionnaires CHQ, which has been used in several studies. A 
generic instrument is useful for determining the relative burden of a disease and made it possible for us to 
compare two forms of allergies. Disease-specific tools are useful due to their increased sensitivity of disease-
specific issues. We did not use a disease specific questionnaire as our purpose was to compare the atopic 
conditions. 
We adjusted for factors that might impact the results, such as age, gender, and asthma and pollen season. 
However, it was not possible to adjust for education and economy, which might influence the HRQL (132-134) 
which is a limitation of the study. Another limitation is the comorbidity within our two study groups in regards 
to allergic diseases. The wheat allergic individuals had pollen allergies and the pollen allergic individuals had 
other food allergies except for wheat allergy.  This is a real life study and it would be difficult to find subjects 
with only one condition. This is a real life study and it would be difficult to find subjects with only one 
condition. A third limitation is the age distribution in the two groups, with younger children in the wheat group 
in comparison with the timothy group. We have therefore interpreted the results from the wheat allergic 
children with caution. 
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6 CONCLUSION 
    
Based on the studies presented, the following conclusions can be drawn: 
 
 Only half of the children challenged with wheat were considered having a wheat allergy and 
consequently many children were unnecessarily on a wheat-free diet. 
 In our population, the level of IgE-ab to ω-5 gliadin, gliadin, HMW-glutenin, and/or LMW-
glutenin discriminate wheat allergic from only wheat sensitized children and also seem to 
predict the severity of the wheat allergy. 
 Basophil stimulation in vitro (CD-sens) in combination with IgE-ab to wheat components may 
be useful when diagnosing wheat allergy. 
 A majority of timothy pollen allergic children had low levels of IgE-ab to wheat but tolerated 
wheat. This dual sensitization is thought to be due to cross-reactivity between timothy 
pollen and wheat but could only be confirmed in a minority of children in inhibition studies. 
 Wheat allergy most likely affect health-related quality of life (HRQL) more than timothy 
allergy, based on parent’s perception. 
 Parent and child perceptions of HRQL appear to be more inconsistent among families with 
wheat allergic, compared to timothy allergic children. 
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7  CLINICAL UTILITY 
In our study only 50 % of the children diagnosed with wheat allergy turned out to have a wheat allergy. This 
reinforces the need for identifying true wheat allergic children thus being able to remove the food restrictions 
for those who are not wheat allergic. We have shown a good correlation between an OFC and IgE-ab to wheat-
specific proteins in determining true wheat allergy patients. 
 Quantification of IgE-ab to ω-5 gliadin, gliadin, HMW-glutenin and LMW-glutenin all seem clinically useful in 
our study population. By combining results from the ω-5 gliadin test, having the highest specificity, with the 
results for gliadin and HMW-glutenin tests, having the highest sensitivities, it was possible to identify all 
children in the positive challenge group. Unfortunately some components we have used are not commercially 
available which means that OFC in clinical practice remains the best option to diagnose true wheat allergy. 
Our HRQL investigations clearly showed that families with a wheat allergic child judged their HRQL significantly 
worse than families with a timothy allergic child.  This emphasizes the importance of a correct diagnosis in 
order to minimize the number of patients with food restrictions. 
8 FUTURE PERSPECTIVES 
Findings of this thesis show that wheat allergy is over-diagnosed among children and has consequences as 
impaired quality of life in general for the families. What we do not know yet is how specific food-related 
situations affect the quality of life in families with a wheat allergic child. Disease-specific questionnaires have 
been used for other food allergens such as milk, egg and peanut but not in a wheat allergy study. Our intention 
is to document also these aspects in order to distinguish between food allergic impact and impact from 
comorbidity. 
 We found that half of the WA group reacted with severe symptoms and they are at risk of anaphylaxis if 
exposed accidently to wheat protein. This is a group that potentially would benefit from oral immunotherapy 
and some attempts have been made globally to treat this patient group. Using omalizumab as protection 
during wheat oral immunotherapy would be an option in order to avoid severe adverse events. 
A new and intriguing problem is the unintentionally ingestion of hydrolysed wheat by the wheat allergic 
patients. We can show that the basophils in WA patients react to HWP as well as to wheat. That is an 
indication that HWP would eventually harm the WA patients if exposed. What needs to be done is to 
document if occasions occur in this group of patients and the severity of the reactions. 
Serology for wheat components is an expanding immunological field and we have documented the clinical 
utility of some gluten-derived components. What further needs to be documented is the role of IgE-ab 
measurements to these gliadin and glutenin components in the cross-reactivity reactions between wheat and 
the other grains such as rye, barley and corn.  We know that the prolamins are present in those grains. Can the 
IgE-ab measurement for these allergens be useful in helping the clinician to advise the WA patients what other 
grain should be avoided or can be included in the diet?  
We could not fully explain the cross reactivity between wheat and timothy pollen and that is an area that 
needs to be exploited in the future. This might not be clinically relevant in terms of management of the WA 
patient but is important in the improvement of diagnosis of wheat and timothy allergies in order to avoid over-
-diagnosis as of today. We found that some wheat allergic patients were CD-sens positive to timothy even 
though they had no symptoms of pollen allergies. It would be of interest to follow up these patients in order to 
evaluate if this method could predict a future pollen allergy.      
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9 SVENSK SAMMANFATTNING 
Bakgrund: 
Överkänslighet mot baslivsmedel som vete, är vanligt förkommande hos små barn. Veteallergi är en 
svår diagnos att ställa. Att en patient är sensibiliserad (har IgE antikroppar (IgE-ak) i blodet) mot vete 
utgör en osäker grund för om patientens behov av en vetefri kost eller ej. I praktiken tolkas ofta 
sensibilisering som allergi och patienterna får strikta dietrestriktioner vilket är näringsmässigt 
ogynnsamt och innebär en försämring av livskvaliteten. Allergin kan diagnosticeras med hjälp av 
patientens sjukhistoria, blodprov och/eller hudprick test samt via födoämnesprovokation. Ett positivt 
blodprov (IgE-ak) eller hudprick test, mot vete, har dock ett begränsat värde för att avgöra om 
patienten riskerar att få allergiska symtom vid intag av vete. Individer sensibiliserade mot vete kan 
uppvisa vete IgE-ak pga. gräs som tillhör samma växtfamilj som vete (Poaceae). Veteproteinet ω-5 
gliadin är välkänt protein. De individer som har IgE-ak mot detta protein anses vara allergiska mot 
vete och kan reagera med allvarlig reaktion. Endast var tredje veteallergiker har IgE-ak mot ω-5 
gliadin. Vi behöver därför identifiera IgE-ak mot andra veteproteiner.  
Basofil stimulering i provrör med allergen mäter basofilcellernas känslighet och är en annan 
diagnostisk metod som kallas CD-sens och har visat sig vara användbar vid diagnostik av t ex 
jordnötsallergi. Med denna metod kan man bestämma den minsta mängden av allergenet som 
stimulerar basofila celler. 
Syfte:  
Att karaktärisera barn och ungdomar med en läkardiagnostiserad veteallergi immunologiskt och 
kliniskt samt att studera hur diagnostiken kan förbättras. Att undersöka korsreaktiviteten mellan 
vete och gräs genom att analysera IgE-ak hos barn och ungdomar med gräspollenallergi.                                                                                                                            
Att kartlägga dessa två patientgruppers livskvalité. 
Material och metoder: 
63 barn med diagnosen veteallergi (vetegruppen) och 72 gräsallergiska barn (gräsgruppen) svarade 
på en livskvalitetsenkät och lämnade blod. Vetegruppen genomgick en öppen veteprovokation, 
patienterna fick under kontrollerade former, äta stigande mängder av vete. IgE-ak mot ω-5 gliadin, 
lågmolekylärt glutenin (LMW-glutenin), högmolekylärt (HMW-glutenin) och mot α-, β-, γ-, and ω-5 
gliadin (gliadin) analyserades i båda grupperna. Blodprov för CD-sens togs för 24 individer i 
vetegruppen. Inhibition används för att analysera om det föreligger en korsreaktivitet mellan vete 
och gräs. Detta görs genom att man till patientens serum tillsätter ett extrakt av ett allergen som 
binder antikroppar mot etta allergen och sedan mäter man den återstående aktiviteten. 
Resultat: 
Hälften av de veteallergiska individerna tålde vete vid provokationen (non-WA). IgE-ak nivån mot 
ω-5 gliadin hos de som uppvisade allergiska symtom vid provokationen (WA) var signifikant högre 
jämfört med non-WA. Alla barn i WA gruppen hade IgE-ak mot ω-5 gliadin, låg resp. högmolekylärt 
glutenin och/eller gliadin. Vi kunde även se en positiv korrelation mellan nivån av IgE-ak mot dessa 
komponenter och allvarlighetsgraden av reaktionen. Flertalet gräsallergiker hade låga nivåer av 
IgE-ak mot vete (median 0.52 kUA/l) och 87 % hade IgE-ak mot björk. Genom inhibition undersökte 
vi om korsreaktivititen mellan gräspollen och vete kunde förklaras av två allergen vanligt 
förekommande i gräs profillin och CCD. Dessa kunde förklara korsreaktiviteten endast i en 
tredjedel av fallen. Både de med vete- och gräsallergi var positiva i CD-sens med stimulering med 
vete respektive gräs. Det fanns en tendens till högre CD-sens värden mot vete hos WA gruppen 
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jämfört med non-WA.  Vetegruppen hade generellt sämre livskvalité än gräsgruppen. Föräldrarna i 
vetegruppen upplevde en signifikant sämre livskvalitet jämfört med gräsgruppen. Barn och föräldrar 
i gräsgruppen hade en god överenstämmelse i sin rapportering men den var sämre i vetegruppen. 
Slutsats: 
Utifrån resultatet i denna avhandling verkar hälften av individerna med en läkarkonstaterad 
veteallergi undvika vete i onödan. Anledningen till detta kan vara att de utvecklat tolerans med tiden 
eller att individen felaktigt diagnosticerats pga. korsreaktivitet med gräspollen. Vi har visat att 
analysera IgE-ak mot gliadiner och gluteniner ökar den diagnostiska träffsäkerheten för veteallergi 
och skiljer ut de med veteallergi från de med IgE-ak mot vete pga. korsreaktivitet med gräs. CD-sens 
med vete har ett begränsat användningsområde men kanske kan ge mer om enskilda veteproteiner 
används för stimulering. Livskvalitén var försämrad i familjerna med ett veteallergiskt barn jämfört 
med familjerna med en gräsallergisk individ. Detta förstärker ytterligare det faktum att diagnostiken 
av veteallergi behöver förbättras för att undvika eliminationskost och oro kring födoämnesallergi. 
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